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ABSTRACT 
 
THE EXAMINATION OF FACTORS THAT INFLUENCE TREATMENT SEEKING 
 
 DELAY AMONG OLDER ADULTS DIAGNOSED WITH  
 
ACUTE MYOCARDIAL INFARCTION 
 
by 
 
                                          DEONNA S. TANNER 
 
   
Early diagnosis and treatment of acute myocardial infarction (AMI) can greatly 
reduce the morbidity and mortality associated with this condition.  However, individuals, 
particularly older adults, delay seeking treatment for AMI symptoms.  The purpose of 
this study was to examine the relationship of factors that influence pre-hospital delay in 
seeking treatment among older adults diagnosed with AMI. 
A descriptive, cross-sectional, comparative study design with a correlational 
component was used.  Data were collected from 82 hospitalized older adults (60-80 years 
of age).  For statistical analyses, older adults were divided into two groups.  The shorter 
delay group delayed ≤ 120 minutes from the onset of symptoms (OS) and the longer 
delay group delayed > 120 minutes.  Using the Common Sense Model as a guide, groups 
were compared on the following variables: internal influences (age, gender, race, history 
of AMI) and external influences (personal and professional support), cognitive 
representations of symptoms (symptom interpretation, perceived level of control, 
seriousness), and emotional representations of symptoms (anxiety and uncertainty).  
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The majority of participants were retired/unemployed (64.6%) White men 
(82.9%) who were married (73.2%) with a mean age of 69.04 (± 5.82) years.  The median 
delay time was 2.6 hours (range 0.5 - 432 hours).  Participants experienced on average 
eight (± 3.86) symptoms (typical and atypical) with high levels of pain (M=7.1 ± 3.4) and 
high state anxiety (M=56.47 ± 10.37) at the time of the AMI.  
Findings show the only significant independent predictor of delay time was 
personal support.  Being more certain that symptoms were heart related or having a 
previous AMI resulted in significantly shorter delay time (p<.05).  Contacting a 
healthcare provider was not helpful for these older adults.  Findings show factors 
influencing delay are challenging and complex, yet laypersons play an important role in 
the decision to seek treatment.  Future research should include community-based 
educational programs focusing on atypical AMI symptoms and ways to increase the 
activation of emergency medical services soon after the OS. 
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CHAPTER I 
INTRODUCTION 
 
Cardiovascular Disease (CVD) is a significant, preventable health problem and 
has been responsible for more deaths worldwide than any other health problem since 
1990 (World Health Organization [WHO], 2008).  In the United States (US), even though 
mortality rates from CVD have to some extent decreased, CVD remains the number one 
cause of death for both men and women (American Heart Association [AHA], 2012a; 
Xu, Kochanek, Murphy, & Tejada-Vera, 2007).  Although CHD indicates a variety of 
acute coronary events, it commonly manifests as an acute myocardial infarction (AMI).   
An AMI is a serious, life-threatening medical event which occurs when the 
coronary blood flow is obstructed, usually from a blood clot, resulting in ischemia to the 
myocardial tissue.  Per current National AHA Emergency Cardiovascular Care (ECC) 
Guidelines, an AMI diagnosis is confirmed by classic electrocardiogram changes (EKG) 
and/or cardiac bio-markers such as elevated cardiac enzymes (troponin I and creatine 
kinase-MB (CK-MB) (Braunwald, 2003).  AMI symptoms are individualized, but typical 
symptoms of AMI are classified as, but not limited to, chest, arm or jaw pain/discomfort, 
shortness of breath (with or without chest pain/discomfort), diaphoresis, and nausea and 
may also include lightheadedness.  After a diagnosis of AMI is confirmed, 
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treatment requires timely medical interventions such as thrombolytic and reperfusion 
therapy to restore the coronary blood flow (AHA, 2010).  The type of intervention 
depends on the patient’s physical manifestations, as well as the extent and features of the 
AMI, but all medical interventions work to restore perfusion and minimize damage to the 
myocardial tissue. 
Statement of the Problem 
Approximately every sixty seconds, at least one person in the US dies from 
complications related to a coronary event such as an AMI (AHA, 2009).  Despite major 
advances in technology resulting in innovative medical reperfusion therapies to 
effectively treat this serious health threat, a majority of individuals with AMI symptoms 
do not seek professional medical treatment in a timely manner.  This delay, known as 
treatment seeking delay (TSD) significantly contributes to the disability and death 
associated with AMI (AHA, 2010).    
TSD remains a global problem even after several decades of scientific research 
and public health initiatives with mass media campaigns that promote the benefits of the 
early recognition of AMI symptoms and timely medical intervention (AHA, 2010; Moser 
et al., 2006).  The initiation of timely treatment must be emphasized as empiric evidence 
from landmark clinical trials demonstrates appropriate medical intervention within one 
hour of the onset of AMI symptoms has the potential to decrease the mortality and 
morbidity associated with AMI by almost half (AHA, 2010; Berger et al., 1999; Simoons 
et al., 1986).  As such, current national AHA (2012a) guidelines recommend appropriate 
medical interventions be administered within one hour of the onset of symptoms (OS) 
also known as the “golden hour”, for maximum reperfusion to occur and to minimize 
damage to the myocardial tissue.  TSD for AMI symptoms not only limits the benefits of 
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appropriate medical interventions; individuals who delay seeking medical care are more 
likely to die en route to the hospital or in the Emergency Department (ED) upon arrival to 
the hospital (AHA, 2009).  In contrast, receiving appropriate medical intervention in a 
timely manner reduces the complexity and lengths of hospital stay for post-AMI patients.  
Evidence also indicates TSD for AMI symptoms is an overall predictor for increased 
patient morbidity and mortality (Gibler et al., 2002; Goldberg et al., 1998; Newby et al., 
1996).   
Purpose/Significance 
The purpose of this study is to examine the relationship of factors which influence 
the prolonged delay in seeking treatment among older adults diagnosed with AMI.   
Although certain factors which influence the decision to delay seeking treatment 
regarding AMI have been identified, additional research in this area is justified as 
findings are inconsistent and gaps in the literature, particularly concerning cognitive, 
emotional, and social influences on time to seek treatment, exist (DeVon, Hogan, Ochs & 
Shapiro, 2010; Moser et al., 2006).  Previous research in this area has focused more on 
socio-demographic and clinical influencing factors, such as the influence of an 
individual’s gender, race, or medical history on time to seek treatment (Dracup & Moser, 
1997; Moser et al., 2006).  To address the gaps in research, this study will use a 
descriptive, cross-sectional, comparative study design to examine the relationship 
between internal (age, gender, race, history of AMI) and external (personal and 
professional support) factors, cognitive (symptom interpretation, perceived level of 
control, seriousness) and emotional (anxiety and uncertainty) representations on time to 
seek treatment (delay time).   
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The focus of this study will be older adults (defined as age greater than 60 years) 
because previous research has focused more on younger populations and older adults are 
underrepresented in research concerning AMI (Dodd, Saczynski, Zhao, Goldberg & 
Gurwitz, 2011; Lee, Alexander, Hammill, Pasquali, & Peterson, 2001).  This is despite 
the fact that those at highest risk for AMI are older adults as the incidence of AMI 
increases with older age.  Presently, the average age for persons with first time AMI is 
64.5 years for men and 70.3 years for women (AHA, 2012a). The researcher chose to 
include ages ranging from 60-80 years as the risk for CVD rises sharply at age 60 and to 
ensure an adequate representation of both genders since males experience AMI at a 
younger age (in the older age group).  
Research focused on older adults is needed as the mortality and morbidity rate for 
AMI is also higher and overall prognosis is worse for those older than age 65 than 
younger populations (Hwang, Ryan, & Zerwic, 2006; Maheshwari, Larid-Fick, Cannon, 
& DeHart, 2000; Popitean et al., 2005; Ryan & Zerwic, 2003).  This age group was also 
chosen because the recognition of AMI symptoms may be more difficult with this age 
group due to age related physical changes and the presence of co-morbidities 
(Gregoratos, 2001; Maheshwari et al., 2000; Tullman, Haugh, Dracup, & Bourguignon, 
2007).  The inability to recognize and identify AMI symptoms may be one of the factors 
which lead to TSD with these older patients.  With the presence of age related changes 
and the fact that at least 50% of older adults have one co-morbidity or more, research 
suggests older adults are more likely than any other age group to present to the ED more 
acutely ill and with a multitude of complicated health issues (Kihlgren, Nilsson, 
Skovdahl, Palmblad, & Wilmo, 2004; Maheshwari et al., 2000).    
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By the year 2030, it is projected one in every five Americans will be over the age 
of 65 and currently, older adults are the chief consumers of healthcare resources.  As this 
population continues to increase, it is imperative for research related to prolonged delay 
in seeking treatment to focus on this vulnerable group as early intervention has the 
potential to decrease the mortality and morbidity associated with AMI (AHA, 2010; Ryan 
& Zerwic, 2003).  As such, this study is necessary as any delay in seeking treatment 
during an AMI may have life threatening consequences which can be prevented.   
Specific Aims 
The specific aims for this study were guided by the Common Sense Model of 
Illness Behavior (CSM) by Leventhal, Meyer, and Nerenz (1980).    
Specific Aim 1:  To examine how delay time was predicted by internal (age, 
gender, race, history of AMI) and external (personal and 
professional support) factors, and cognitive (symptom 
interpretation, perceived level of control, seriousness) and 
emotional (anxiety and uncertainty) representations of 
symptoms.    
Specific Aim 2:  To examine the relationship of cognitive and emotional 
representations of symptoms on delay time and the 
contribution of external influencing sources, personal 
support (helpfulness of laypersons).  
Specific Aim 3:  To explore the differences in the level of personal support 
(helpfulness of laypersons) in making the decision to seek 
treatment between older adults who present for treatment in 
< 120 minutes compared to those who delay > 120 minutes.   
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Specific Aim 4:  To explore the differences in the level of professional 
support (helpfulness of healthcare professionals) in making 
the decision to seek treatment between older adults who 
present for treatment in < 120 minutes compared to those 
who delay >120 minutes.    
Specific Aim 5:  To explore the differences in cognitive representation of 
identity/cause (AMI symptom interpretation) between older 
adults who present for treatment in < 120 minutes compared 
to those who delay > 120 minutes.    
Specific Aim 6:  To explore the differences in the level of cognitive 
representation of controllability (perceived control over AMI 
symptoms) between older adults who present for treatment 
in < 120 minutes hours compared to those who delay > 120 
minutes. 
Specific Aim 7:  To explore the differences in the cognitive representation of 
timeline/consequence (perceived seriousness of AMI 
symptoms) between older adults who present for treatment 
in < 120 minutes compared to those who delay > 120 
minutes. 
Specific Aim 8:  To explore the differences in the emotional representation of 
anxiety regarding AMI symptoms between older adults who 
present for treatment in < 120 minutes compared to those 
who delay > 120 minutes.   
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Specific Aim 9:  To explore the differences in the emotional representations 
of uncertainty regarding AMI symptoms between older 
adults who present for treatment in < 120 minutes compared 
to those who delay > 120 minutes.   
Research Questions: 
1.  What are the coping processes (symptom management strategies) used by 
older adults in an attempt to control or cure AMI symptoms?  
2.  What is the relationship of initial cardiac enzyme levels (troponin I and 
CK-MB) to patient’s perceptions of the cognitive representation of the 
seriousness of their AMI symptoms?  
Theoretical Framework 
The CSM is the theoretical framework chosen to help guide the study design.  
Formerly known as the Theory of Self-Regulation (SRT), the CSM conceptualizes an 
individual as a capable and effective problem solver who has common sense beliefs 
which act to guide behavior in response to a health threat (Difenbach & Leventhal, 1996; 
Hagger & Orbell, 2003; Leventhal, Leventhal, & Contrada, 1998; Leventhal et al., 1980; 
Leventhal, Nerenz, & Steele, 1984).  These common sense beliefs are known as illness 
representations and are based largely on internal influencing sources (socio-demographic 
variables) and external influencing sources (social support) which assist an individual to 
make sense of and cope with health and illness (Difenbach & Leventhal, 1996; Leventhal 
et al., 1980; Leventhal et al., 1984).    
Since the 1980s this theory has been extensively used to understand how 
individuals perceive, manage, and cope with a broad range of illnesses.  Previous studies 
using the CSM include, but are not limited to research on kidney disease, pulmonary 
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illness, diabetes mellitus, venous thrombosis, and certain types of cancer (Fowler 
Kirchner, Kuiken, & Baas, 2007; Hagger & Orbell, 2003; Kapstein, et al., 2007; Kelly et 
al., 2005; McAndrew et al., 2008; O’Neill, 2002).  This model has also been used as a 
theoretical framework for previous nursing research in an attempt to understand the 
decision making process related to seeking treatment for an AMI symptoms (Dracup et 
al., 1995; Dracup et al., 2009; Goff et al., 1999; Harralson, 2007; King & McGuire, 2007; 
McKinley, Moser, & Dracup, 2000; Meischke, Eisenberg, Shaeffer, & Henwood, 2006; 
Meischke et al., 1999; Ryan & Zerwic, 2003; Tullman et al., 2007; Zerwic, 1998; Zerwic, 
1999; Zerwic, King, & Wlasowicz, 1997; Zerwic, Ryan, DeVon, & Drell, 2003).    
Concepts of the Common Sense Model of Illness Behavior 
The major concepts of CSM are the cognitive and emotional illness 
representations and subsequent coping processes.  Within the model, these coping 
processes are followed by the concept of appraisal, which is the evaluation of the coping 
processes in order to manage a health threat.  According to the theory, the process begins 
when an individual perceives a threat to health through the experience of physical 
manifestations of illness, known as symptoms.  When a health threat is perceived, an 
individual progresses through three stages: mental representations of the health threat 
(cognitive and emotional aspects), coping actions/behaviors designed in an attempt to 
manage the health threat, and appraisal of how well the coping procedures managed the 
health threat (Difenbach & Leventhal, 1996 Leventhal et al., 1980; Leventhal et al., 
1984).  In order to illustrate the relationships among the major concepts, an illustration of 
the CSM is presented in Figure 1.  
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Figure 1.  Common Sense Model of Illness Behavior (Leventhal & Cameron, 1987; Leventhal et al., 1980).   
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Overview of the Illness Representations 
The cognitive and emotional illness representations are the crux of this theoretical 
model and are defined as an individual’s perceived susceptibility of the health threat and 
subsequent mental interpretation of the illness (Leventhal & Cameron, 1987; Leventhal et 
al., 1998).  Illness representations are individualized and are made up of simultaneous 
cognitive and emotional responses to the health threat.  The cognitive element of illness 
representation has five major concepts which are identified within the CSM.  These 
concepts include: identity, cause, controllability, timeline, and consequences of the 
illness.  Simultaneous with the development of these representations are the 
individualized emotional representations experienced by the individual (Figure 1).    
According to the CSM, illness representations are influenced by internal and 
external influencing sources which assist an individual in making sense of and coping 
with health and illness (Difenbach & Leventhal, 1996).  Internal influencing sources 
include socio-demographic and clinical factors, previous experience with health and 
illness, as well as objective knowledge, expectations, and beliefs about the health threat 
(Difenbach & Leventhal, 1996).  Another internal source within the model that influences 
how a person responds to a health threat is an individual’s cultural/social role.  External 
influencing sources include one’s social network which may consist of other people 
including, but not limited to, spouses or significant others, family, friends and even 
healthcare providers.  These sources may be positive influences helping to prompt action 
in an attempt manage a health threat or negative influences impeding action against a 
threat (Leventhal & Cameron, 1987).    
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Cognitive Illness Representations: The Concepts of Identity and Cause 
Identity is the first concept of the cognitive illness representations.  Identity is not 
only the name or label of the health threat; it also includes the perceived relationship 
between the health threat and the associated physical symptoms (Difenbach & Leventhal, 
1996).  Labeling the illness is based on previous experience and expectations regarding 
the illness or disease.  Cause is the concept which is linked to identity.  This concept 
relates to the individual’s belief about the probable origin of the health threat.  Probable 
causes of illness may include biological, emotional, environmental, and psychological 
(Fowler et al., 2007; Hagger & Orbell, 2003).    
Identity and cause are recognized within the literature as being important in 
explaining the decision making process related to seeking treatment for an AMI.   
Identifying symptoms associated with AMI is difficult because symptoms are 
individualized; many persons, particularly women and older adults, do not experience 
typical symptoms.  Typical symptoms include chest, arm or jaw pain, shortness of breath 
(with or without chest discomfort), diaphoresis, lightheadedness, and may also include 
nausea (AHA, 2010).  There is scientific evidence which suggests women and older 
adults are more likely to experience atypical AMI symptoms.  These atypical symptoms 
may include, but are not limited to, abdominal pain, confusion, nausea and/or vomiting, 
chest tightness (not described as pain), dizziness, dyspnea, shoulder/back pain, headache, 
and weakness (Gregoratos, 2001; Johansson, Stromberg, & Swahn, 2004; McSweeney 
Cody, & Crane, 2001; McSweeney et al., 2003; McSweeney, Lefler, & Crowder, 2005; 
Sjostrom-Strand & Fridlund, 2008; Song, Yan, Yang, Sun, & Du, 2010; Tullman et al., 
2007; Xanthos et al., 2010).  Experiencing atypical AMI symptoms makes it difficult for 
individuals to identify symptoms as heart-related which subsequently may delay the 
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decision to seek treatment (Moser et al., 2006).  There is empiric evidence which has 
been consistent over time, demonstrates that individuals whose physical symptoms of 
AMI match their perceived expectations, make the decision to seek treatment sooner than 
those whose expectations and symptoms do not match (Horne, James, Petrie, Weinman, 
& Vincent, 2000; Johnson & King, 1995; McKinley et al., 2000; Noureddine, Arevian, 
Adra, & Puzantian, 2008; Ruston, Clayton, & Calan, 1998).  On the other hand, when 
discrepancies between expected AMI symptoms and experienced symptoms occur, 
individuals delayed seeking treatment (Albarran, Clarke, & Crawford, 2007; Banks & 
Malone, 2005; Hwang et al., 2006; Johansson et al., 2004; Kentsch et al., 2002; King & 
McGuire, 2007; Lovelin, Schei, & Hole, 2007; Martin et al., 2004; McSweeney et al., 
2001; McSweeney et al., 2003; Moser, McKinley, Dracup, & Chung, 2005; Zerwic et al., 
2003).      
Cognitive Illness Representations: The Concept of Controllability 
Controllability is also known as the cure/control concept.  This concept refers to 
the individual’s beliefs of personal and medical control over the prevention, progression, 
and/or recovery from a health threat (Difenbach & Leventhal, 1996; Hagger & Orbell, 
2003).  These perceptions are influenced by the responsiveness to interventions initiated 
to manage a health threat.  According to the CSM, if the intervention does not have the 
desired effect and symptoms are not cured or controlled (noted during the appraisal 
process), individuals are prompted to implement a new strategy to manage or recover 
from the health threat (Leventhal & Cameron, 1987).  Empiric evidence demonstrates 
individuals who attempt to control or cure their symptoms delay seeking treatment for 
AMI significantly longer than those who do not (Clark, 2001; Leslie, Urie, Hooper, & 
Morrison, 2000; Lovelin et al., 2007; Turis, 2009).  Furthermore, having the ability to 
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control symptoms is noted as a significant predictor of prolonged pre-hospital delay for 
individuals with AMI symptoms (Lesneski, 2009).   
Cognitive Illness Representations: The Concepts of Timeline and Consequence 
Timeline is related to one’s beliefs about the expected duration and course of the 
illness as well as expected recovery time (Leventhal et al., 1998).  This concept includes 
the individual’s perception about whether the health threat is acute (short term or 
temporary), chronic (long term), or cyclic (long term with acute exacerbations).   
Timeline is linked to consequence in the model.  Consequence is the belief about the 
repercussions of the health threat on the physical, economic and/or social aspects of an 
individual’s daily life.  Examples of consequences of illnesses may include loss in one’s 
social role, economic hardship, disability and even death (Difenbach & Leventhal, 1996).   
Within the context of AMI and delay, evidence from previous studies demonstrates 
individuals who perceive AMI symptoms to be temporary or without life-threatening 
consequences delay seeking treatment longer than those who do not (Banks & Dracup, 
2006; Moser et al., 2005; Taylor, Garewal, Carter, Bailey, & Aggarwal, 2005).  In 
addition, not taking symptoms seriously is noted as significant predictor for delay in the 
decision to seek treatment for AMI (Johansson et al., 2004; Kentsch et al., 2002).   
Emotional Illness Representations 
Emotional Representations are parallel to the cognitive representations within the 
CSM (Figure 1).  Emotional Representations are essential elements which also guide 
decision making invoking emotional reactions in response to the health threat.  These 
emotional reactions are highly individualized and may include emotions such as worry, 
anxiety, uncertainty, anger, stress, and fear (Difenbach & Leventhal, 1996).  According to 
the model, if the emotional element is accompanied by some type of action plan, 
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individuals are motivated to take action against a health threat.  If the emotional element 
becomes too overwhelming, emotions may consume the cognitive illness representation, 
which results in minimal or no coping processes (Difenbach & Leventhal, 1996).    
Emotional Representations are conceptualized in this study as anxiety and 
uncertainty regarding symptoms experienced.  Feelings of uncertainty and anxiety are the 
most consistently noted emotional responses to AMI symptoms within the literature 
(Banks & Malone, 2005; Henriksson, Lindahl, & Larsson, 2007; Khraim, Scherer, Dorn, 
& Carey, 2009; Lesneski, 2009; Moser et al., 2005; Pattenden, Watt, Lewin, & Stanford, 
2002; Taylor et al., 2005).  Anxiety regarding AMI symptoms is also identified as a 
significant predictor of reduced delay time (Khraim et al., 2009; McKinley et al., 2000).  
In contrast, uncertainty regarding AMI symptoms significantly adds to the prolonged 
delay in seeking treatment for AMI symptoms (Kentsch et al., 2002; McKinley et al., 
2000; Pattenden et al., 2002; Taylor et al., 2005).   
Coping Processes 
In order to manage a health threat, the individual uses coping processes also 
known as symptom management strategies.  These processes are relative to the perceived 
susceptibility of the health threat and involve taking action to manage cognitive and 
emotional illness representations (McAndrew et al., 2008).  Cognitive coping processes 
are used to diminish the perceived susceptibility of the health threat, while emotional 
coping processes are intended to diminish emotional reactions.   
The Concept of Appraisal 
The CSM is completed with the concept of appraisal.  In this phase, an individual 
evaluates the effectiveness of his/her coping strategies against the health threat 
(Difenbach & Leventhal, 1996).  This phase acts as a feedback loop.  If the coping 
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strategies were appraised to be ineffective, the representations will be altered which leads 
to new coping strategies in an attempt to manage or recover from the health threat (Figure 
1).  If the strategies for coping are appraised to be effective, these strategies may 
influence the illness representations and could be used as future coping efforts by the 
individual (Difenbach & Leventhal, 1996).   
Rationale for the Selection of the Theory 
There is no theoretical model to date which solely focuses on the decision making 
process related to seeking treatment for an AMI.  There are, however, several models 
used in previous, scholarly studies in an attempt to explain how individuals respond to a 
health threat.  The CSM is the chosen framework because the concepts and relationships 
within the model have been tested over many years.  This theory is well-established and 
is the theory most often used to guide research to examine the decision making process 
related to seeking treatment for AMI symptoms (Byrne, Walsh, & Murphy, 2005; Dracup 
et al., 2009; Dracup et al., 1995; Goff et al., 1999; Harralson, 2007; King & McGuire, 
2007; McKinley et al., 2000; Meischke et al., 2006; Meischke et al., 1999; Ryan & 
Zerwic, 2003; Tullman et al., 2007; Walsh, Lynch, Murphy, & Daly, 2004; Zerwic, 1998, 
1999; Zerwic et al., 1997; Zerwic et al., 2003).  Although most previous studies focused 
on the cognitive component of this theory, the CSM recognizes the cognitive illness 
representations, as well as the emotional representations in response to a health threat. 
This is most appropriate for this study as results from previous research demonstrates that 
the decision making process is complex and emotional representations may be important 
influences on the decision to seek treatment (Byrne et al., 2005; Walsh et al., 2004).   
This theoretical model will assist the investigator to examine the relationship between 
internal (age, gender, race, history of AMI) and external (personal and professional 
  
 
16 
 
 
support) influencing factors, cognitive (symptom interpretation, perceived level of 
control, seriousness) and emotional (anxiety and uncertainty) representations on delay 
time.  A deeper understanding of the factors which influence the decision to seek 
treatment for AMI symptoms may lead to interventions and educational strategies which 
significantly reduce delay times and consequently, minimize the disability and death 
associated with AMI in the future.   
Limitations of the Theory 
Although the CSM is a useful framework to guide the study design, no theory is 
without limitations.  Some scholars argue the CSM is too complex with numerous 
concepts.  Even so, the theory and its concepts are not difficult to understand.  Another 
criticism is that although the support from others is acknowledged as an influencing 
factor, this influence is not emphasized as a major concept in the model.   
Although the CSM is the selected theory, this theoretical model will need to be 
modified for this research study.  The modified CSM is presented in Figure 2.  Within the 
context of this research, the health threat is defined as physical symptoms of AMI.  
According to the CSM, if symptoms are perceived as a health threat, actions are 
promoted by the coping processes.  In the modified version of the CSM, cognitive 
representations are reflected by an individual’s symptom interpretation, the perceived 
level of control over symptoms, and perceived level of seriousness of symptoms.  Internal 
influencing sources such as socio-demographic (age, gender, race) and clinical factors 
(history of AMI) as well as external influencing sources (personal and professional 
support) are also included. 
In the modified CSM, parallel to the cognitive representations are the emotional 
representations which in the original model describe the general, emotional distress 
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reaction when an individual experiences an illness or disease.  Although there are many 
emotional responses which may be experienced in response to AMI symptoms, feelings 
of uncertainty and anxiety are the focus of this study because these emotions are the ones 
most commonly described in the literature.  Next in the adapted model are the coping 
processes (symptom management strategies) which are determined by the cognitive and 
emotional representations.  Lastly, the desired outcome by the individual will be the 
determination of action of seeking timely treatment for AMI symptoms.  Appraisal will 
not be included in the adapted model as the feedback loop of this phase in the original 
model is not relevant as individuals who participate in the study will have already 
experienced an AMI and sought treatment for their symptoms.  An illustration of the 
adapted model is included (Figure 2).   
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Figure 2.  Investigator’s theoretical framework adapted from the Common Sense Model of Illness Behavior (Leventhal et al., 1998).   
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Theoretical Assumptions  
For the purpose of this study, the investigator will acknowledge the following 
theoretical assumptions:  
1.  Delay in seeking treatment for AMI symptoms is common and limits the 
benefits of medical reperfusion therapies, greatly contributing to the 
disability and death associated with AMI.    
2.  The ED is the major point of entry into the healthcare system where AMI 
is most likely to be diagnosed and treatment initiated. 
3.  Individuals are capable problem solvers with the ability to make decisions 
in response to a health threat.   
4.  Individuals have implicit beliefs about health and illness and when illness 
is perceived to be enough of a health threat, a coping response will be 
initiated by the individual.   
5.  The decision to seek treatment is greatly influenced by the support from 
one’s social network (including laypersons and healthcare professionals).    
6.  Feelings of uncertainty and anxiety may alter an individual’s perception 
of the importance of seeking timely medical treatment.   
Summary 
TSD remains a global problem and contributes significantly to the disability and 
death associated with AMI.  This study examines the relationship between factors which 
influence the prolonged delay in seeking treatment among older adults diagnosed with 
AMI.  A deeper understanding of the factors which influence the decision to seek 
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treatment may lead to interventions and educational strategies which significantly reduce 
delay times and consequently, minimize the disability and death associated with AMI.  
  
 
21 
 
 
 
 
 
 
CHAPTER II 
REVIEW OF THE LITERATURE 
 
This chapter provides a review of recent literature on TSD as it relates to AMI. 
This literature review begins with a thorough definition and description of the types of 
delay.  Next, influencing factors on delay such as clinical and patient characteristics will 
be described.  Lastly, cognitive, emotional, and social influences will be discussed.  
Overall, this chapter is a synthesis of what is currently known regarding these concepts in 
relation to TSD related to AMI.  
The amount of time that elapses from the OS to an individual’s presentation for 
medical treatment has a significant effect on the extent of the disability and deaths related 
to AMI.  Any prolonged delay after the onset of the physical manifestations of AMI has 
life-threatening consequences as empirical evidence demonstrates reperfusion therapies 
have the greatest benefit when administered within one hour after OS.  To facilitate 
timely treatment, the AHA (2012b) strongly recommends all individuals wait no longer 
than five minutes before activating emergency medical services (EMS) by dialing 911, at 
the OS.  This has also been advertised in numerous public service and mass media 
campaigns which emphasize the importance of seeking timely medical treatment.  
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Even so, individuals of all ages, particularly older adults, continue to delay 
seeking treatment.  
Description of Treatment Seeking Delay 
Many individuals with AMI symptoms do not seek professional medical treatment 
in a timely manner.  This delay, known as TSD, significantly contributes to the disability 
and death associated with AMI (AHA, 2010).  There are several descriptions of delay 
noted within the AMI literature.  
Total delay time is defined as the time interval from the OS to the initiation of 
medical interventions.  The most common medical intervention is reperfusion therapy 
which is usually initiated in the ED (Moser et al., 2006).  Although investigators have 
separated total delay time in a variety of ways, pre-hospital, transport, and intra-hospital 
delays are the three major types of delay related to AMI that have been examined within 
the literature (Waller, 2006).  
Pre-hospital delay time, also known as the patient delay, is defined as the time 
interval from the OS to the patient’s decision to seek care.  However, total pre-hospital 
delay time is commonly measured as the time interval from the OS to hospital 
presentation, usually through the ED (Lefler & Bondy, 2004; Waller, 2006).  Transport 
delay is defined as the time interval from the decision to seek treatment to hospital 
arrival.  Although this type of delay may be considered a part of the pre-hospital phase, it 
has most often been examined as a separate entity.   
Intra-hospital delay, also known as “door to treatment time”, is defined as the 
time interval from the patient’s hospital arrival to the initiation of medical treatment 
(Khraim et al., 2009).  The current AHA nationwide recommendation for hospitals is to 
provide treatment for AMI symptoms within 30 minutes of ED arrival (AHA, 2010). 
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Transport and intra-hospital delay times have significantly decreased over the past decade 
due to the initiation of such standardized treatments and effective triage protocols.  These 
protocols, implemented primarily through the AHA and the National Heart Attack Alert 
Program (NHAAP), an initiative of the National Heart Lung and Blood Institute 
(NHLBI), have decreased transport and intra-hospital delay times which are insignificant 
when compared to pre-hospital delay times (Holliday, Lowe, & Outram, 2000; Moser et 
al., 2006).  
Pre-hospital delay is the focus of this review of literature on TSD and AMI.  It is 
described as the most challenging type of delay as it relates to the patient’s decision to 
seek treatment for AMI symptoms (DeVon et al., 2010; Kentsch et al., 2002; Luepker, 
2005; McKinley et al., 2000; Moser et al., 2006; Moser et al., 2005; Ottesen, Dixen, 
Torp-Pedersen, & Kober, 2003; Xanthos et al., 2010; Zerwic, 1998, 1999).  This decision 
making process is multi-dimensional and the decision to seek treatment has many 
influencing factors which may prompt or hinder the decision to seek treatment.  
Although the health outcomes of patients are dependent on seeking treatment in a 
timely manner, current literature provides evidence that TSD for AMI symptoms is 
common.  Specifically, pre-hospital delay times for both men and women with AMI 
symptoms range from 1.4 to 6.4 hours (DeVon, Ryan, Ochs, & Shapiro, 2008; Dracup et 
al., 2003; Gibler et al., 2002; Goldberg et al., 2009; Kentsch et al., 2002; McKinley et al., 
2000; Ottesen et al., 2003; Perers et al., 2004; Popitean et al., 2005; Rasmussen, Munck, 
Kragstrup, & Haghfelt, 2003; Saczynski et al., 2008; Taylor et al., 2005; Thuresson, et al,  
2007; Ting et al., 2008; Zerwic et al., 2003).  This is despite serious efforts over the past 
two decades to reduce mortality and morbidity associated with AMI by emphasizing the 
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importance of seeking timely treatment (Caldwell & Miaskowski, 2002; DeVon, et al., 
2010; Dracup et al., 2003; Moser et al., 2006; Moser et al., 2005; Tullman et al., 2007).  
As such, additional research in this area is justified as TSD for AMI symptoms not only 
limits the benefits of appropriate medical interventions, individuals who delay seeking 
medical care are more likely to die en route to the hospital or in the ED (AHA, 2009).  
Furthermore, evidence from previous sentinel studies indicates TSD for AMI symptoms 
is not only a predictor of increased patient morbidity and mortality; timely interventions 
reduce the complexity and length of hospital stay for post-AMI patients (Gibler et al., 
2002; Goldberg et al., 1998; Newby et al., 1996; Zerwic, 1999).  As pre-hospital delay 
remains problematic and is the type of delay most associated with the risk of disability 
and death, it is the focus of this research. 
Health Threat  
The physical manifestations of an AMI (health threat) are known as symptoms.  
The quantity and severity of symptoms experienced as a result of an AMI can act as a 
major stimulus in the decision of whether or not an individual chooses to seek medical 
treatment in a timely manner (DeVon et al., 2008; Hwang, Ryan, & Zerwic, 2006).  
However, AMI symptoms are not always easily recognized as heart related and 
consequently, seeking medical treatment may be delayed.  
Anecdotally, crushing, mid-sternal chest pain radiating down the left arm is the 
symptom most portrayed in print and media as the classic sign of an AMI for both men 
and women.  Scientific research, however, provides evidence the symptom experience 
associated with AMI is highly individualized. The AHA (2012b) has classified the typical 
symptoms of AMI as often having a sudden onset and lasting more than about 15 
minutes.  Classic AMI symptoms include chest, arm or jaw pain/discomfort, shortness of 
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breath (with or without chest pain/discomfort), diaphoresis, lightheadedness, and nausea 
(AHA, 2012b).  These symptoms may increase or weaken in intensity and may occur 
alone or in combination.  Importantly, the chief reported AMI symptom experienced by 
both men and women remains chest pain/discomfort (AHA, 2012b; DeVon & Ryan, 
2005; Moser et al., 2006).  AMI symptoms, however, may also manifest gradually and 
the previously mentioned symptoms may be less intense and intermittent, also described 
as stuttering symptoms (AHA, 2011; Canto et al., 2007).  These less intense symptoms 
are vague and are classified as “atypical” in nature.  This makes it even more difficult for 
individuals to identify and recognize them as related to the occurrence of an AMI.  
Atypical AMI symptoms are described as vague in which the predominant 
symptom is not limited to chest pain/discomfort (Canto et al., 2007).  Atypical AMI 
symptoms may include, but are not limited to, unexplained difficulty in breathing and 
pain/discomfort in locations other than the chest, such as the arm(s), shoulder, back, jaw, 
and/or epigastric area.  Patients have also reported atypical AMI symptoms such as dull 
chest discomfort, indigestion, nausea, vomiting, diaphoresis, feelings of faintness, 
dizziness, fatigue, generalized weakness, heart palpitations, and cardiac arrhythmias 
(AHA, 2010; Arslanian-Engoren, 2005; Canto et al., 2007; DeVon & Ryan, 2005; 
Johansson et al., 2004).  These atypical AMI symptoms usually do not last for prolonged 
periods of time and may occur alone or in combination (AHA, 2011; DeVon & Ryan, 
2005; Canto et al., 2007).  
Individuals may also experience types of atypical symptoms that occur over an 
extended period of time which act as precursors to the occurrence of an AMI.  These 
symptoms are known as prodromes to an AMI and are described as intermittent with 
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increases in frequency and intensity over time (McSweeney et al., 2003; McSweeney et 
al., 2005; McSweeney, Cleves, Zhao, Lefler, & Yang, 2010).  Although men and women 
both report experiencing prodromal AMI symptoms, there is empirical evidence 
signifying women are more likely to experience these symptoms (Arslanian-Engoren, 
2005; McSweeney et al., 2003; McSweeney et al., 2005; McSweeney et al., 2010).  At 
present,  reported prodromal symptoms are very similar to the previously described 
atypical AMI symptoms and may also include fatigue, anxiety, difficulty sleeping, 
sweating, gastrointestinal upset, cough, loss of appetite, vision changes, headache, 
flushing, and sensations of choking (Albarran et al., 2007; King & McGuire, 2007; 
McSweeney et al., 2001; McSweeney et al., 2003; McSweeney et al., 2010).  In general, 
these prodromal symptoms are reported as subtle and occur several days, or even up to 
one month prior to an AMI.  Evidence continues to emerge suggesting prodromal 
symptoms may also be an important indicator predicting the severity of acute AMI 
symptoms (McSweeney et al., 2003).  
Prodromal and atypical AMI symptoms are alike as they are non-specific in 
nature and do not match the classic AMI symptoms most often portrayed in print and 
media.  As such, individuals who lack knowledge of such AMI symptoms are likely to 
attribute symptoms to less complex health issues and/or aging.  This makes it problematic 
for individuals to seek treatment for their symptoms in a timely manner, which is why 
AMI symptoms, particularly atypical symptoms, are identified as an influencing factor on 
TSD (Albarran et al., 2007; Arslanian-Engoren, 2005; Kimble et al., 2003; McSweeney 
et al., 2001; McSweeney et al., 2003; Ottesen et al., 2003; Schoenberg, Peters, & Drew, 
2003b; Zerwic, 1999).  
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The AMI Symptom Experience of Older Adults  
Aging is a progressive, biologic process which results in a decline in the structure 
and function of bodily processes.  This decline allows for the older adult to be more 
susceptible to illness and research findings suggest aging makes it difficult for older 
adults to discern between age-related physical changes and certain disease processes 
(Gregoratos, 2001; Porth, 2006).  In particular, research demonstrates older adults’ acute 
AMI symptoms may be masked by age-related physiologic changes and other chronic 
health conditions, particularly diabetes mellitus (DM).  As such, older adults may delay 
seeking treatment for AMI longer than other younger age groups without such health 
conditions.  This was noted in the landmark Worchester Heart Attack Study in which 
older age and the presence of DM was significantly associated with a delay in seeking 
treatment greater than two hours (Yarzebski, Goldberg, Gore, & Alpert, 1994).   
Similar findings were noted in the Global Utilization of Streptokinase and Tissue 
Plasminogen Activator for Occluded Coronary Arteries (GUSTO-I) and the Global Use 
of Strategies to Open Occluded Arteries (GUSTO-III), trials which will be discussed 
more in-depth later in this chapter (Gibler et al., 2002).  In these landmark studies, 
significant delays in seeking treatment were noted for older adults (particularly women) 
with a history of DM.  Similar results were also found in a comparative study by 
McKinley et al. (2000) in which those with a diagnosis of DM delayed significantly 
longer than those without a diagnosis of DM.  Along with the neuropathy caused by DM, 
older adults, in general, have overall decreased pain sensation so even if older adults do 
present with classic chest pain, it is likely to be described as less severe than younger age 
groups (Gregoratos, 2001; Johansson et al., 2004; Porth, 2006).  Furthermore, as a result 
of aging, older adults are more likely than younger individuals to be diagnosed with 
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multi-vessel heart disease due in part to loss of distensibility of arteries, resulting in an 
unremarkable electrocardiogram (EKG) (known as silent ischemia).  This makes a 
diagnosis of AMI difficult for individuals as well as healthcare professionals, and may 
add to pre-hospital and intra-hospital delay times (Maheshwari, 2000).  
Due to age related changes and co-morbidities, older adults are more likely than 
younger age groups to experience atypical AMI symptoms and therefore, have a diverse 
clinical presentation in the ED.  Hwang and colleagues (2006) noted participants age 65 
or older were significantly less likely to report chest pain when compared to younger age 
groups; rather older adults (65 and older) reported sweating or nausea.  Furthermore, 
these older adults experienced overall fewer symptoms compared to those less than 65 
years of age.  In a descriptive study by Johansson et al., (2004) in which the median age 
was 64 years, older adults who experienced atypical symptoms like fatigue or dull pain, 
delayed seeking treatment significantly longer and 20% of the older adults diagnosed 
with AMI (n=110) did not experience any chest pain.  Kentsch et al. (2002) observed 
older adults whose symptoms were perceived to be mild or intermittent also delayed 
significantly longer than those whose symptoms were perceived as more threatening.  
Influencing Sources 
Internal Influencing Sources 
Socio-demographic factors often influence the incidence and presentation of 
certain illnesses.  CHD is a health problem that affects men and women of all ages and 
races.  Age, gender, and race have been identified as non-modifiable risk factors for 
CHD.  These factors are also recognized as factors predicting prolonged delay in seeking 
treatment for symptoms of AMI and numerous studies have focused on these patient 
characteristics as factors associated with TSD related to AMI.  
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Older Age  
Those at highest risk for AMI are older adults as the incidence of AMI increases 
with age (AHA, 2010).  Although most CHD studies focus on younger populations, older 
age has been identified as a socio-demographic variable which is significantly associated 
with delay of treatment for an AMI (Gibler et al., 2002; Goff, 1999; Goldberg et al., 
2009; Johansson et al., 2004).  In addition, age greater than 65 years is reported to be an 
independent predictor for TSD related to AMI (Blohm, Hartford, Karlsson, & Herlitz, 
1998; Kentsch et al., 2002; Ryan & Zerwic, 2003).  However, results are contradictory as 
other studies have found no association between older age and prolonged pre-hospital 
delay time (Lesneski, 2009; Rasmussen et al., 2003; Thuresson et al., 2007).  Inconsistent 
findings indicate a need for additional research that focuses on older adults with AMI.   
The most well-known multi-center trial in the area of TSD and AMI is the Rapid 
Early Action for Coronary Treatment (REACT) trial (Brown et al., 2000; Goff et al., 
1999).  Although it took place in the mid-1990s, REACT remains the largest study of its 
kind to date.  The intent of this landmark, multi-community randomized trial was to 
diminish delay for individuals with AMI symptoms through the implementation of a 
community-based intervention in 20 US communities (10 matched pairs, n=61,043).  
Data from the REACT trial demonstrates delay was longer among older patients when 
compared to younger patients.  Specifically, delay time increased by 14 minutes for each 
10-year increment in age (Goff, 1999).  
Similarly, in two other landmark, multi-national, randomized clinical trials of 
fibrinolytic therapy for patients with AMI, older age was significantly associated with 
delay (Gibler et al., 2002).  In these trials, known as GUSTO-I and GUSTO-III, delays in 
seeking treatment were examined (n=27,849).  These large trials provide evidence that 
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TSD influences mortality as delays greater than one hour were significantly associated 
with increased mortality as evidenced by in-hospital and 30-day mortality rates (Gibler et 
al., 2002).  
The Global Registry of Acute Coronary Events (GRACE) project is another 
multi-national study providing empirical evidence that older age is a factor significantly 
associated with delay in seeking treatment for symptoms of AMI.  Delay was examined 
in 14 countries (n=44,695) and older age was significantly associated with delay in 
seeking treatment (>2 hours) in all geographic regions.  An earlier prospective, 
longitudinal study whose focus was older adults further supports the association between 
older age and prolonged pre-hospital delay (Blohm et al., 1998).  The delay time for 
patients younger than age 71 (n=893) in this study was two hours, while those older than 
71 (n= 834) had a median delay time of 2.5 hours.  Not only was there a significant 
correlation between older age and prolonged delay time, the three independent predictors 
for prolonged pre-hospital delay were older age, female sex, and a history of 
hypertension.  
These results are similar to a comparative study by Kentsch et al. (2002).  The 
median delay time for all participants (n=739) was three hours, but age greater than 65 
was an independent predictor for prolonged delay greater than one hour (Kentsch et al., 
2002).  Likewise, McKinley et al. (2000) compared factors which affected treatment 
seeking behavior among North American (n=277) and Australian patients (n=147) 
diagnosed with AMI.  Participants in both geographic areas had a delay time of greater 
than 1.5 hours.  In addition, older age was significantly associated with longer delay 
among North American participants from the US and Canada, but not with Australian 
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participants.  It is important to note, however, this finding could be attributed to a smaller 
number of Australian participants in the study when compared to North American 
participants (147 versus 277, respectively).  
In contrast, results from other studies have found no statistically significant 
associations between older ages and delay (Lesneski, 2009; Rasmussen et al., 2003; 
Thuresson et al., 2007).  Overall, the sample sizes of these studies were smaller (with the 
exception of Thuresson et al., 2007).  These opposing findings may also be due in part to 
methodological issues.  For example, the focus of Rasmussen et al.’s (2003) study was 
delay from the onset of chest pain that was suggestive of acute coronary syndrome; it was 
not specific to patients diagnosed with AMI.  In fact, only one-third of participants in this 
study (n=337) had a confirmed diagnosis of AMI.  Lesneski (2009) used a small non-
random sample of 105 participants, all of whom were Caucasian and 69.5% were men.  
Although the sample in the study by Thuresson et al. (2007) was large (n=1,939), a large 
majority of the sample (75%) were men.  Furthermore, there was no consistent time 
frame reported that was used to collect data after hospital admission in this study.  
Inconsistencies in data collection are considered a limitation and may account for the 
conflicting study findings.  
Female Gender  
Until recent years, women were, for the most part, excluded in clinical research 
trials concerning AMI as heart disease was thought to be a gender specific problem 
affecting only men (Ashton, 1999; Banks & Dracup, 2006; O’Donnell, Condell, Begley, 
& Fitzgerald, 2006).  Additional research over the past two decades however, provides 
evidence that CHD is a serious health concern for both genders, as cardiovascular disease 
continues to be the leading cause of death for both men and women in the US (AHA, 
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2012a).  As such, gender specific research concerning women, heart disease and AMI is 
increasing (AHA, 2009; Lovelin et al., 2007; McSweeney et al., 2001; McSweeney et al., 
2003).    
Evidence indicates women delay seeking treatment when experiencing symptoms 
of AMI and female gender is recognized as a socio-demographic factor which influences 
delay (Moser et al., 2006).  This is in spite of the fact that women have higher mortality 
rates post-AMI and are more likely than men to experience a second AMI within ten 
years following a previous AMI (Moser et al., 2006).  Furthermore, women are at 
increased risk for serious health complications post AMI such as heart failure (Holliday 
et al., 2000) and report overall poorer mental health after an AMI (AHA, 2009; Kamm-
Steigelman, Kimble, Dunbar, Sowell, & Bairan, 2006).  These poorer health outcomes 
could be contributed to prolonged delay in seeking treatment for AMI symptoms.   
Results from a number of studies demonstrate female gender is an independent 
socio-demographic factor which is significantly associated with delay (Blohm et al., 
1998; Finnegan et al., 2000; Gibler et al., 2002; Johansson et al., 2004; Moser et al., 
2006; O’Donnell et al., 2006; Perers et al., 2004; Shin, Martin, & Suls, 2010; Ting et al., 
2008).  Specifically, pre-hospital delay times for women have ranged from 1.8 to 14 
hours (Arslanian-Engoren, 2005; Banks & Malone, 2005; Banks & Dracup, 2006; 
Harralson, 2007; Khraim et al., 2009; Moser et al., 2005; O’Donnell et al., 2006; Zerwic 
et al., 2003).  The literature offers common explanations for these prolonged delays 
which are specific to women.  More information related to this phenomenon will be 
described later in this chapter.  
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In general, women may not experience typical AMI symptoms and are more 
likely to have varied, atypical AMI symptoms such as progressive fatigue, dyspnea, 
dizziness, indigestion, nausea, generalized weakness, sleep disturbances, and neck, 
scapulae, and/or back pain (Arslanian-Engoren, 2005; Ashton, 1999; Chen, Woods, & 
Puntillo, 2005; Holliday et al., 2000; King & McGuire, 2007; Lovelin et al., 2007; 
McSweeney et al., 2001; McSweeney et al., 2003; Shin et al., 2010; Zerwic, 1998; 
Zuzelo, 2002).  Some women experience no chest pain as noted in a qualitative study by 
Arslanian-Engoren (2005) in which only three out of ten women participants experienced 
any type of chest pain prior to their AMI diagnosis.  The experience of atypical AMI 
symptoms may make it difficult for women to make the decision to seek treatment as 
symptoms are not recognized as heart related (Arslanian-Engoren, 2005; McSweeney et 
al., 2001; McSweeney et al., 2003; Moser et al., 2006). 
A woman’s social role is a major psychosocial factor influencing the decision to 
delay seeking treatment.  ‘Competing social demands’ was a common theme which 
emerged in a phenomenological study by Schoenberg et al. (2003b) in which women 
(n=40) reported household and social responsibilities as reasons for delay in seeking 
treatment for AMI symptoms.  Likewise, a phenomenological analysis of interviews by 
Zuzelo (2002) found women did not want to disrupt their daily routines with family and 
instead, prioritized household duties while ignoring their AMI symptoms.  
Not only do women ignore their symptoms, they report feelings of denial 
regarding AMI symptoms which subsequently influences their decision to delay seeking 
medical treatment.  Denial and disbelief were common themes in response to AMI 
symptoms noted by women participants in two studies which utilized a grounded theory 
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approach (Holliday et al., 2000; Rosenfeld & Gilkeson, 2000).  Holliday and colleagues 
reported women (n=16) did not believe themselves to be susceptible to AMI and 
therefore, delayed seeking treatment with a delay time of 6.3 hours after OS.  Similarly, 
the theme of ‘discounting of symptoms’ emerged in a study by Banks and Malone (2005) 
whose focus was African-American (AA) women with cardiac symptoms.  A perceived 
‘lack of susceptibility’ to AMI was a theme which emerged in findings by MacInnes 
(2006) in which women (n=10) believed they were not at risk for AMI, despite being 
previously diagnosed with CHD.  Results from a more recent qualitative study suggest 
women with a known diagnosis of CHD (n=7) did not perceive themselves at high risk 
for cardiac problems such as AMI, because with CHD, they were primarily asymptomatic 
(Moore, Kimble, & Minick, 2010).   
Arslanian-Engoren (2005) found women (n=10) were likely to deny symptoms of 
AMI by associating their symptoms to insignificant health problems such as the stomach 
flu, being overweight and/or menopause.  A phenomenological study by Zuzelo (2002) 
women (n=10) reported similar results.  Likewise, Albarran et al. (2007) and Sjostrom-
Strand and  Fridlund (2008) found women attributed their AMI symptoms to less serious 
conditions or to the aging process and subsequently, delayed seeking treatment.  
Similarly, a comparative study by Noureddine and colleagues (2008) found 
women were reluctant to bother others about their symptoms and wanted to ‘wait and 
see’ if symptoms would subside.  Important to note that even though there were twice as 
many men enrolled in this study (n=212), only the women reported being reluctant to 
seek treatment for AMI symptoms.  Similarly, other studies found not wanting to bother 
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others was significant with the women participants, but not with the men (Banks & 
Dracup, 2006; McKinley et al., 2000; Moser et al., 2005). 
In contrast, studies with smaller sample sizes and less sophisticated statistical 
analyses demonstrated that the association between delay and female gender may be of 
clinical significance, but the results were not statistically significant (Ashton, 1999; 
Banks & Dracup, 2006; DeVon, et al., 2010; Harralson, 2007; King & McGuire, 2007; 
Lesneski, 2009; Moser et al., 2005; Noureddine et al., 2008; Zerwic et al., 2003).  
Findings regarding the significance of the influence of gender may have conflicting 
results due to methodological issues as many studies have not enrolled adequate numbers 
of female participants to detect differences between men and women.  Larger sample 
sizes and the enrollment of women in equitable proportion to men may allow for a more 
suitably powered sample to detect significant differences in future studies.  
Race  
The influence of race/ethnicity on TSD related to AMI has been examined and 
evidence over time strongly suggests minority status is an influencing factor on TSD 
(Arslanian-Engoren, 2005; Goff et al., 1999; Lee, Bahler, Chung, Alonzo, & Zeller, 
2000; Zerwic et al., 2003).  Although the largest growing US minority group at present is 
Latinos, investigators have focused research more on the differences between non-
Hispanic Whites and non-Hispanic Blacks also known as AA (Moser et al., 2006). 
Studies show that AA, in particular, are a demographic group identified at high risk for 
delay (Lee et al., 2000; Sullivan et al., 2009; Zerwic et al., 2003) and when compared to 
Caucasians, AA also have a higher risk of heart disease which may manifest as an AMI 
(AHA, 2010).  
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Results from the previously discussed REACT trial, also indicate that race is an 
influencing factor on TSD for non-Hispanic Blacks.  The pre-hospital delay time was 
significantly longer among non-Hispanic Blacks compared to non-Hispanic Whites (Goff 
et al., 1999).  Similarly, Zerwic et al. (2003) examined differences in delay across gender 
and race in a sample of hospitalized non-Hispanic Blacks and non-Hispanic White 
patients (n= 212).  Non-Hispanic Blacks delayed significantly longer than non-Hispanic 
Whites (3.25 hours versus 2 hours, respectively) and race was a significant predictor in 
determining whether or not treatment was sought by study participants within one hour of 
OS.  Lee and colleagues (2000) examined delay times and AMI symptoms in non-
Hispanic Blacks and non-Hispanic Whites.  Results support previously mentioned studies 
as non-Hispanic Blacks delayed significantly longer than non-Hispanic Whites. 
Although evidence suggests there are differences in TSD between races, the 
explanations for these differences remain unclear.  Scholars argue cultural differences in 
the perception of and response to AMI symptoms may explain differences in time to seek 
treatment (Moser et al., 2006; Zerwic, 1999).  Others argue the minorities’ symptom 
experience is much different from that of non-Hispanic Whites, as minorities report less 
intense painful symptoms (Brown et al., 2000) and may present to the hospital with 
dyspnea or fatigue instead (Lee et al., 2000).  However, uncertainty also lies in the fact 
that TSD has not been investigated thoroughly across all races and ethnicities, as few 
studies focus solely on minority groups such as non-Hispanic Blacks, Latinos, 
Asian/Pacific Islanders, and Native Americans (Moser et al., 2006; Zerwic et al., 2003).  
History of AMI  
Clinical factors, such as history of an AMI are expected to influence TSD. 
Although it may be assumed individuals who have experienced a prior AMI would be 
  
37 
 
 
more aggressive in seeking treatment for AMI symptoms, evidence suggests otherwise. 
Data from previous research demonstrates a prior AMI or being identified as high risk for 
AMI due to a diagnosis of CHD, angina, hypertension, hypercholesterolemia, or DM, 
does not necessarily influence the timeliness in seeking medical care (Gibler et al., 2002; 
Leslie et al., 2000; McKinley et al., 2000; Moser et al., 2006; Thuresson et al., 2007).  
Furthermore, individuals with previously mentioned risk factors may be uninformed 
these are risk factors for AMI (DeVon & Ryan, 2005). 
In the Worcester Heart Attack Study, individuals with a medical history of 
diabetes and/or prior AMI delayed significantly longer (>2 hours) than those without 
such a medical history (Yarzebski et al., 1994).  Similar results were also found in other 
studies in which individuals with a history of AMI or angina delayed significantly longer 
than those who had not experienced an AMI (Blohm et al., 1998; Goff et al., 1999; 
McKinley et al., 2000; Rosenfeld, 2004).  However, findings are inconsistent as other 
studies show those with a history of AMI sought treatment significantly sooner than those 
without a history (Gibler et al., 2002; Khraim et al., 2009; Perkins-Porras, Whitehead, 
Strike, & Steptoe, 2009) or that medical history had no significant influence on delay 
time (Dracup et al., 2003; Johansson et al., 2004; Song et al, 2010).  One plausible 
explanation for these inconsistent findings may be that those who have a subsequent AMI 
may be able to more readily identify symptoms as cardiac in nature which makes the 
decision to seek treatment easier.  However, if the symptoms with a subsequent AMI do 
not correspond with their previous experience, these patients may dismiss symptoms as 
having a non-cardiac origin and prolong the decision to seek treatment (Pattenden et al., 
2002).  Furthermore, individuals with a prior history of AMI or CHD are also more likely 
  
38 
 
 
to become hemodynamically unstable rapidly, which may account for a decreased delay 
time (Popitean et al., 2005).  Notably, all of the mentioned studies reported that when 
AMI symptoms persisted and/or increased in intensity, individuals were prompted to 
make the decision to seek treatment.  Although results are conflicting, it is worthy to note 
individuals who have experienced a previous AMI are as likely to delay as those with no 
medical history of AMI.  
External Influencing Sources 
The context in which symptoms begin also influences the decision to seek 
treatment.  Evidence indicates an individual’s physical location when symptoms begin 
can increase delay time, especially if the individual is home alone.  In contrast, being 
with a family member or other companion facilitates seeking treatment (Banks & Dracup, 
2006; Perry, Petrie, Ellis, Horne & Moss-Morris, 2001; Raczynski et al., 1999).   
When an AMI begins, most individuals are likely to contact a member of their 
social network such as a spouse, family member, co-worker or a healthcare professional 
(HCP) such as general practitioner (GP) (Keenan, 2001; Perry et al., 2001; Thuresson et 
al., 2007).  This is despite the recommendation by the AHA (2012a) to wait no longer 
than five minutes before activating EMS by dialing 911 at the OS of an AMI.  As such, 
one’s network of social support is a contextual factor which has been shown to influence 
an individual’s decision to seek treatment when experiencing symptoms of an AMI.  
Social support is also an influence on seeking treatment in the heart failure and stroke 
literature (Friedman & Quinn, 2008; Zerwic, Hwang, & Tucco, 2007).  
Personal Support  
Overall, results from current literature suggest contacting a family member is a 
positive influence which prompts the decision to seek professional medical treatment. 
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The influence of others emerged as a theme in a phenomenological study by Keenan 
(2001).  This results from this sample of 10 participants indicated the presence of others 
was advantageous when experiencing AMI symptoms.  These ‘others’ facilitated 
participants’ seeking treatment by actions such as promptly calling an ambulance.  These 
findings are similar to findings by Thuresson and colleagues (2007) who identified 
encouragement from a family member or friends was a statistically significant reason for 
the decision to seek care for 1,939 patients in a national survey of 11 hospitals in Sweden. 
Likewise, Kentsch et al. (2002) noted that asking others for advice about symptoms 
reduced the risk of delay.   
Laypersons were instrumental in making the decision to seek treatment for 
middle-aged and older adults in a mixed methods study by Schoenberg, et al. (2003a).  In 
this sample of 1,388 post-AMI patients, it was reported that most commonly a spouse or 
adult child made the decision to seek medical treatment on behalf of the older adult 
experiencing AMI symptoms.  When compared to those less than 50 years of age, the 
older adults of this sample were significantly more likely to have others make their 
decision to seek treatment.  Specifically, 44% of those 60-70 years of age and 49.2% of 
those age 70 and older reported someone else made their decision for them. Similarly, 
Lesneski (2009) reported that telling someone else (a layperson) about their symptoms 
was an independent predictor of decreased delay for this sample.  Only one study which 
examined the influence of others on delay found no significant association (Quinn, 2005). 
Although the result was not significant, those who contacted a friend or family member 
had a shorter time to seek medical care than those who did not, suggesting clinical 
significance. 
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Professional Support  
While the influence of family and friends facilitates the decision to seek medical 
treatment, research demonstrates that older adults, in particular, have a tendency to seek 
advice from an HCP such as a physician, which substantially increases time to seek 
treatment.  Results from a mixed methods study by O’Donnell and colleagues (2006) 
demonstrated older adults who sought advice from their physicians delayed almost four 
hours longer than those who did not.  Similarly, King and McGuire (2007) found older 
adults presenting to the ED in less than one hour had not contacted a physician, while 
those who did, delayed significantly longer.  Hwang et al. (2006) noted if an older adult 
contacted a physician, he/she was significantly more likely to delay seeking treatment 
greater than one hour.  Johansson et al. (2004) also found contacting a GP was 
significantly associated with prolonged delay time greater than one hour for study 
participants.  This was supported in a study by Leslie and colleagues (2000) in which a 
majority of Swedish participants initially called their GP at OS resulting in over a four 
hour delay in seeking treatment for 40% of this sample (n=313).  Participants in this 
study were also hesitant to call the ambulance and reported that calling their GP should 
be their initial action instead of activating EMS.  Likewise, Taylor and colleagues (2005) 
found seeking support from a GP was significantly associated with the decision to delay 
in this study of Australian AMI patients.  Interestingly, none of these studies mentioned 
to whom these patients spoke or what instructions they were given by their physicians.  
This is identified as an obvious gap within the literature and indicates a need for 
additional research in this area.  
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Cognitive Representations of AMI 
Identity and Cause of Symptoms  
Explanations for prolonged delay have been linked to a lack of cognitive 
representations of AMI symptoms.  As stated, the AMI symptom experience is highly 
individualized and numerous studies have examined how patients perceive and identify 
their AMI symptoms and how these perceptions contribute to prolonged delay. 
Furthermore, individuals who experience atypical symptoms, particularly women and 
older adults, rarely reported these types of symptoms to their HCP and typically 
dismissed them as insignificant or a normal part of aging (McSweeney et al., 2001; 
McSweeney et al., 2003; McSweeney et al., 2005).  Notably, these symptoms are most 
often dismissed by women. 
One of the three major themes which emerged in a phenomenological study by 
Banks and Malone (2005) was ‘misrecognition and discounting of symptoms’.  This 
study’s focus was the experiences of AA women seeking care for cardiac symptoms 
(n=12).  The median delay time was 1.8 hours and participants did not identify their 
symptoms as cardiac in nature and therefore, delayed seeking treatment.  Importantly, 
these AA women did not recognize atypical AMI symptoms and therefore, did not relate 
the cause to the heart.  For instance, one participant reported her stomach hurt worse than 
her heart and consequently, she did not associate her symptoms as cardiac.  Albarran et 
al. (2007) also recognized that atypical symptoms influenced treatment seeking behaviors 
among women (n=12) with no previous history of AMI.  Women in this study noticed 
gradual physical changes such as breathlessness over a period of weeks, but blamed their 
symptoms on other less serious health conditions which contributed to the delay in 
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seeking treatment.  Each of these studies however, focused solely on women so their 
findings may be difficult to generalize.   
The results of a large, comparative study by Kentsch et al. (2002) also provide 
evidence that misrecognition of symptoms, contributes to delay.  Using face to face 
interviews, patients were questioned about their reasons for prolonged delay in seeking 
treatment, attitudes toward symptoms, and coping strategies in the acute phase of AMI.  
Participants (n= 739) who correctly identified symptoms as cardiac, delayed less than one 
hour.  Those who delayed more than one hour assumed their symptoms were not related 
to the heart or simply denied their symptoms.  Not recognizing symptoms were related to 
the heart was also a significant factor associated with delay in seeking treatment in a 
study by Vavouranakis et al. (2010).  
Zerwic et al. (2003) examined differences in delay in a sample of hospitalized 
patients diagnosed with AMI (n= 212).  When participants experienced symptoms which 
matched their expectations of AMI symptoms, they were less likely to delay seeking 
treatment as symptoms were recognized as cardiac in nature.  These findings are 
supported in a correlational study by King and McGuire (2007) in which an equal number 
of hospitalized men and women (n=60) were interviewed post AMI.  Fifty-six percent of 
participants who delayed less than one hour reported their symptoms matched their 
expectations of AMI; experiencing symptoms which were similar to their expectations 
explained 14% of the variance in predicting time to seek care.  Horne and colleagues 
(2000) had similar findings in a descriptive study of 88 hospitalized AMI patients.  A 
discrepancy between expected AMI symptoms and actual experienced symptoms was 
cause of prolonged delay in seeking treatment for 58% of participants.  Those without 
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typical chest pain/discomfort, delayed significantly longer than those who experienced 
the classic chest pain/discomfort.  Other scholars also found a significant association 
between prolonged delay and a lack of similarities in experienced and expected 
symptoms (Hwang et al., 2006; Johansson et al., 2004; Lovelin et al., 2007; Moser et al., 
2005).    
Cure and Controllability of Symptoms  
Studies also provide evidence that individuals attempt to cure or control their 
AMI symptoms instead of immediately seeking appropriate medical treatment.  A 
phenomenological study by Clark (2001) examined commonalities in treatment decision 
making in the early stages of AMI in the United Kingdom (UK).  Participants (n=14) 
reported their decision making was influenced by failed attempts to control, manage, or 
cure their symptoms.  Reported strategies by these participants to cure or control 
symptoms included administration of medications, resting, attempting to sleep, and 
applying pressure to painful areas.  Despite the use of self-care strategies, one of the 
themes which emerged in this study was ‘increasing crisis’.  As this theme implies, when 
AMI symptoms persisted and/or increased in intensity over time, participants concluded 
they could not cure or control the symptoms without professional medical assistance.  As 
noted with other studies, this ‘increasing crisis’ was one of the final motivating factors in 
seeking treatment (Clark, 2001).  
Scientific evidence demonstrates the more individuals attempt to control or self-
manage their symptoms, the greater the delay in seeking treatment.  Ruston and 
colleagues (1998) interviewed British AMI patients’ and individuals who were present at 
OS. Participants were divided into three groups, non-delayers (delay < 4 hours), delayers 
(delay 4-12 hours), and extended delayers (delay >12 hours) based on length of time 
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between the OS and presentation for treatment.  The delayers and extended delayers 
reported using strategies to control or cure their symptoms more so than the non-delayers.  
Of interest is that a greater proportion of non-delayers were less than 65 years of age 
(Ruston et al., 1998).  Similarly, a qualitative study by Henriksson and colleagues (2007) 
used six focus groups with AMI patients (n=13) and their relatives (n=14) to examine 
thoughts and actions after the onset of AMI symptoms.  A majority of participants 
incorrectly interpreted symptoms as non-threatening and took their own action in 
response to AMI symptoms such as taking medications for pain, gastrointestinal (GI) 
upset and/or tried to rest to ease their symptoms.  These actions resulted in an increase in 
delay and as noted in other studies, only after symptoms persisted did participants seek 
professional medical treatment.  
Other studies support these findings.  A comparative study of Norwegian patients 
with first time AMI found attempts to cure or control symptoms influenced prolonged 
delay (Lovelin et al., 2007).  Thirty-three percent of women and 25% of men self-
medicated in an attempt to control or cure AMI symptoms in this study.  Other coping 
processes or self-management strategies which contributed to delay in this study included 
sitting or lying down to rest.  Leslie and colleagues (2000) reported almost one-quarter of 
participants with and without a history of AMI (n=313) delayed more than one hour after 
the OS in an attempt to control their symptoms using self-management techniques.  
Those without a history of AMI or angina thought their symptoms would ‘go away’ and 
those with a history of AMI attempted to control their symptoms through administration 
of nitrates and other medications.  Likewise, in a comparative study of factors influencing 
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treatment seeking delay for patients with AMI, having the ability to control symptoms 
was found to be a significant predictor of prolonged delay time (Lesneski, 2009).  
Timeline and Consequences of Symptoms  
Many individuals perceive their symptoms (of AMI) to be temporary or less 
serious, without life threatening consequences and therefore, delay seeking medical 
treatment.  Intermittent or stuttering symptoms described as symptoms which ‘came and 
went’, was a significant, independent factor on prolonged delay time for 150 participants 
in a cross sectional survey by Taylor et al. (2005).  Intermittent symptoms were also a 
major reason for prolonged delay reported by 61 AA men and women in a comparative 
study by Banks and Dracup (2006).  Similarly, the occurrence of intermittent symptoms 
was a significant cause for delay in a study by Moser et al., 2005.  
In contrast, individuals who perceive AMI symptoms to be serious with life-
threatening consequences may delay less than those who do not.  Johansson et al. (2004) 
used a descriptive study design to identify factors which influenced participants’ (n= 403) 
decision time regarding seeking treatment for symptoms of AMI.  Two-thirds of 
participants did not take their symptoms seriously and reported they did not know the 
consequences of not promptly seeking treatment.  Not taking symptoms seriously was a 
significant predictor for pre-hospital delay in other studies as well (Kentsch et al., 2002; 
Vavouranakis et al., 2010). 
Emotional Representations  
Feelings of Uncertainty  
Emotional representations of uncertainty and anxiety are common responses to 
symptoms of AMI.  Individuals uncertain about their symptoms hesitate to attribute their 
symptoms to the heart (Banks & Malone, 2005; Henriksson et al., 2007; Pattenden et al., 
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2002).  Findings from a comparative study to examine gender differences (Moser et al., 
2005) demonstrate that individuals who were uncertain about their AMI symptoms did 
not want to worry others in case their symptoms were not of a serious nature.  This 
finding was statistically significant only with the women participants.    
Other individuals who experienced AMI symptoms demonstrated feelings of 
uncertainty simply by ignoring AMI symptoms or by waiting for them to subside.  
‘Waiting to see’ (if symptoms would subside) was a significant predictor of delay for 
both men and women in a comparative study by Khraim and colleagues (2009).  
Similarly, ‘symptom uncertainty’ emerged as a theme explaining delay in a sample of 
women (n= 40) who were interviewed about perceptions of cardiac symptoms and time to 
treatment (Schoenberg et al., 2003b).  The majority of women participants in this study 
reported being confused by atypical symptoms such as fatigue, nausea, and/or neck pain.   
As a result, these women self-diagnosed themselves and delayed seeking treatment. 
Uncertainty is also recognized in a study on intent to delay by Zapka et al. (2000) 
in which participants (n=1,294) were surveyed via the telephone to examine their 
knowledge, attitudes, and beliefs regarding AMI symptoms.  Those surveyed were asked 
if they would ‘wait until they were very sure’ their symptoms were heart related or if they 
would ‘seek treatment right away’ for symptoms possibly related to AMI.  Those more 
certain in recognizing their symptoms had less intent to delay seeking treatment.  These 
findings are consistent with other studies which found uncertainty regarding AMI 
symptoms significantly influenced prolonged delay in seeking treatment (Kentsch et al., 
2002; McKinley et al., 2000; Pattenden et al., 2002; Taylor et al., 2005).  
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Feelings of Anxiety  
Anxiety is a commonly reported emotion in response to AMI symptoms and is 
recognized as an influencing factor associated with TSD.  A study comparing delay times 
between Jordanian men and women diagnosed with AMI provided evidence that 
increased anxiety about symptoms was a significant predictor of reduced delay for 
participants (n=134) (Khraim et al., 2009).  In this study, a higher level of anxiety 
regarding AMI symptoms had a significant, inverse relationship with decision delay time 
indicating as anxiety increased, delay time decreased.  It is worthy to note this study was 
conducted in an eastern cultural context with only a very small percentage of women 
(17.9%) included as participants.        
Results from Moser et al. (2005) demonstrated anxiety was a common emotional 
response to AMI symptoms which influenced time to seek treatment.  In this study, there 
was a main effect of anxiety regarding AMI symptoms on delay time.  Patients (n=194) 
who experienced more anxiety regarding symptoms, delayed significantly less than those 
with lower anxiety levels.  This study is not typical of a majority of studies reviewed as 
there was a purposeful effort to enroll an equal number of both men and women (n= 98 
and n= 96, respectively).  Similarly, in a comparative study of hospitalized patients with 
AMI by Lesneski (2009), 72% of the participants reported feelings of mild (33.3%), 
moderate (20%), very (14.3%), or extreme anxiety (4.8%) regarding symptoms related to 
AMI.  However, anxiety was not significantly associated with delay in seeking treatment 
with this sample of participants.  Results could be due to the small number of participants 
enrolled in the study (n=105). 
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Summary 
Many patients who experience AMI symptoms do not make the decision to seek 
medical treatment in a timely manner and TSD remains a global phenomenon.  Even 
though most studies focus on younger age groups, older adults, in particular, are 
especially vulnerable to delay.  Researchers have identified influences on delay that 
include certain socio-demographic and clinical factors, as well as cognitive and emotional 
representations of symptoms.  In addition, certain contextual factors such as an 
individual’s physical location and level of social support influence the decision to seek 
treatment as well.  Additional research in this area is justified as findings are inconsistent 
across studies and gaps in the literature are noted particularly concerning cognitive, 
emotional, and social influences (DeVon et al., 2010; Moser et al., 2006).  
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CHAPTER III 
 
METHODOLOGY 
 
This chapter describes the methodology used to conduct this study.  This chapter 
consists of a description of the study design, setting, and sample.  In addition, the 
instruments used to measure study variables, specific data collection procedures, as well 
as methods to ensure the protection of human subjects are explained.  Lastly, an overview 
of the data analyses is discussed.     
Study Design  
This study used a descriptive, cross-sectional, comparative design to examine two 
groups of older adults (> 60 to 80 years of age) with a confirmed diagnosed of AMI.  
Those who presented for treatment in < 120 minutes after OS were categorized into the 
shorter delay group and those who delayed > 120 minutes were categorized into the 
longer delay group.  Groups were compared on the following variables: internal 
influencing sources (age, gender, race, history of AMI) and external influencing sources 
(personal and professional support), cognitive representations of symptoms (symptom 
interpretation, perceived level of control, seriousness), and emotional representations of 
symptoms (anxiety and uncertainty).   
This study also has a correlational component wherein the relationship between 
internal and external influencing sources and cognitive and emotional representations on 
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time to seek treatment (delay time) were examined.  Data were collected from 
participants at one time point during hospitalization soon after admission when the 
patient was hemodynamically stable and willing to participate.  In-person interviews 
using semi-structured questionnaires with closed and open-ended questions were used to 
collect data.  These questionnaires were read to the participant by the investigator to 
reduce the possibility of missing data, ensure accuracy, and limit personal bias. 
Setting 
A non-random sample of 82 hospitalized older adults with a confirmed diagnosis 
of AMI was recruited from one private, not-for-profit, 481-bed acute-care facility in the 
metro-Atlanta area of Georgia.  This hospital, Piedmont Healthcare (PHC), was chosen 
for its large cardiac patient population.  PHC reports that it has over 26,000 general 
inpatient admissions yearly and in 2011 performed 1,742 open heart/thoracic surgeries 
and 9,278 cardiac catheterizations (including angioplasty) (Piedmont Healthcare, 2011).  
Hospitalized post-AMI patients were recruited soon after hospital admission when they 
were confirmed to be in stable condition in the intensive care unit (ICU), cardiac care unit 
(CCU) or cardiac step-down unit(s).  
The rationale for collecting data from hospitalized patients is that the AMI was 
recently experienced and the collection of data soon after the event reduces recall bias. 
As such, the retrospective account of the AMI experience was assumed to be more 
accurate.  Obtaining data in the hospital setting has been a successful method in similar 
scholarly studies (Banks & Dracup, 2006; Dracup et al., 2003; Johansson et al., 2004; 
Khraim, Scherer, Dorn, & Carey, 2010; Lesneski, 2009; Moser et al., 2005; Noureddine 
et al., 2008; Rasmussen et al., 2003; Zerwic et al., 2003; Zerwic, personal 
communication, March 4, 2011).   
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Sample 
This convenience sample consisted of 82 hospitalized older adults (> 60 to 80 
years of age) who had recently experienced an AMI.  For the purposes of this study and 
in accordance with the AHA definition, an AMI is defined as death or damage to the 
heart muscle due to an insufficient blood supply (AHA, 2012b).  An AMI diagnosis was 
confirmed using classic electrocardiogram changes (EKG) and/or specific cardiac bio-
markers, such as elevated cardiac enzymes (troponin-I and Creatine Kinase-MB (CK-
MB).  These cardiac bio-markers are the most highly sensitive diagnostic parameters for 
AMI and are consistent with those collected in previous studies (Dracup et al., 2003; 
Moser et al., 2005; Zerwic et al., 2003).   
Hospitalized patients were recruited to participate if they met the following 
inclusion criteria:  (a) had a medical diagnosis of AMI that was confirmed by classic 
electrocardiogram changes (EKG) and/or abnormal cardiac bio-markers such as elevated 
cardiac enzymes (troponin-I and CK-MB);  (b) were in a hemodynamically stable 
condition confirmed by stable vital signs and being free of chest pain and/or discomfort at 
the time of the interview;  (c) were between 60 and 80 years of age ;  (d) had the ability to 
read, write, and speak English without difficulty;  (e) were alert and oriented to person, 
place, time, and situation, with no history of cognitive impairment.  As previous research 
indicates, there is little difference in the delay times between those with prior and first 
time AMI (Moser et al., 2006).  Therefore, individuals diagnosed with a previous AMI 
were included as participants if the previously mentioned inclusion criteria were met.   
Exclusion criteria for this study included a diagnosis of cognitive impairment 
and/or an acute mental illness or a critical, terminal illness.  These exclusions were 
necessary as the researcher did not want to cause undue burden on those with acute 
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mental or terminal illnesses.  Participants were also excluded if the AMI was a 
subsequent medical diagnosis and not the initial reason for seeking treatment.  As delay 
time is a major study variable, it would have been inappropriate to enroll those who 
subsequently experienced an AMI while in the ED or after hospital admission.  Potential 
participants screened for eligibility from September 2011 through March 2012. Of these 
older adults, 82 met eligibility criteria and agreed to participate.  Most potential 
participants were excluded based on the required age criteria.  There were four potential 
participants who met eligibility criteria, but refused to participate.     
Calculations to estimate sample size for this study were based upon current 
literature, the design of the study, and the number of variables being measured (Field, 
2009).  An a-priori power analysis to estimate sample size was done using a free on-line 
statistical calculator (Soper, 2011).  This analysis was done with consideration  of the 
most complex research hypothesis (in this case, multiple regression analyses) and to 
control for Type I and Type II errors, as well as effect size, and the tailedness of the test 
(Cohen, 1992; Field, 2009).  With consideration to six predictors in the model, a power 
analysis estimated that a total sample size (N) of 75 would be needed to meet the study 
aims using a standard alpha (α) level set at 0.05 for a two tailed test, with an medium 
effect size of 0.20 and a standard power of 0.80.  A sample of 82 older adults was 
recruited and the integrity of the study was maintained as described in Chapter 4.  
Although this study has a cross-sectional design, attrition was still considered.  If 
a participant had withdrawn from the study at the time of data collection, another 
participant would have been recruited.  However, there were no patients who withdrew 
from the study.  
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Measurements 
Myocardial Infarction Symptoms Survey 
A synopsis of the theoretical concepts, variables to be measured, the selected 
instruments and how they were measured and scored is provided (Appendix A).  The 
main questionnaire used to collect most of the data for this study is the Myocardial 
Infarction Symptoms Survey (MISS), a combination of two well established, 
psychometrically sound descriptive instruments: the Myocardial Infarction Symptom 
Profile (MISP) and the Modified Response to Symptoms Questionnaire (m-RSQ).  A 
copy of the MISP with permission to use and modify this instrument was granted by the 
author, Dr. Julie Zerwic (Appendix B).  A copy of the m-RSQ with permission to use and 
modify the m-RSQ was granted by the author, Dr. Kathleen Dracup (Appendix C).  A 
copy of the MISS is provided (Appendix D). 
The MISP was chosen specifically because of its focus on the symptoms 
experienced during AMI, as well as actions taken as a result of those symptoms (Zerwic 
et al., 2003).  This instrument consists of yes/no questions and open-ended questions 
which elicit a short answer response from the participant regarding AMI 
symptomatology.  As this instrument is descriptive and there is no cumulative score, 
reliability testing was not appropriate.  However, the MISP has been previously reviewed 
for content validity by a panel of cardiology experts and has also been substantiated 
through comparison of this instrument to two well established instruments which measure 
cardiac symptoms (Zerwic et al., 2003).  Through expert review, this instrument is known 
to measure typical and atypical symptoms experienced by the patient throughout the 
stages of AMI.  It has also been used in previous nursing studies examining reasons for 
delay in seeking treatment for AMI symptoms (Hwang et al., 2006; Zerwic et al., 2003).  
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The RSQ was originally developed by Burnett, Blumental, Mark, Leimberger, and 
Califf (1995) to identify factors related to TSD and AMI and was later modified to 
include additional cognitive, emotional, and social factors which have been identified as 
gaps in previous research (Moser et al., 2006).  The modifications of the m-RSQ resulted 
in a total of 21 questions with two question types: a forced multiple-choice response set 
and a five-point Likert scale to measure participants’ responses to the AMI symptoms.  
The m-RSQ is a descriptive instrument which can be administered in an interview type 
format.  The modified version obtains data in six domains including (a) the context in 
which AMI symptoms appeared,  (b) antecedents of symptoms,  (c) emotional responses 
to symptoms,  (d) behavioral responses to symptoms,  (e) cognitive responses to 
symptoms, and (f) response of others (limited to lay persons) to symptoms (Dracup & 
Moser, 1997).   
Individual items are used as subunits of analysis and similar to the MISP, the m-
RSQ does not yield a total score.  As such, reliability testing was not appropriate for this 
instrument.  However, content validity for the m-RSQ has been established by a panel of 
expert cardiovascular nurses with advanced degrees (Master’s) and was found to be a 
valid measure of factors influencing delay in seeking treatment for AMI (Dracup & 
Moser, 1997; Reilly, Dracup & Dattolo, 1994).  The m-RSQ has also been used in 
similar, scholarly studies in an attempt to explain TSD regarding AMI (Banks & Dracup, 
2006; Dracup & Moser, 1997; Dracup et al., 2003; Khraim et al., 2009, 2010; Lesneski, 
2009; McKinley et al., 2000; Noureddine et al., 2008).  
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Health Threat 
Physical Symptoms of AMI.  Health threat was measured using items 16, 17, 
and 18 from the MISS which consist of an exhaustive list of typical and atypical AMI 
symptoms which may have been experienced by the patient.  Item 16 is a list which 
determines the location(s) where patients experienced typical pain/discomfort when 
having AMI symptoms.  These locations include, but are not limited to chest, arm, 
shoulder, neck, back, and abdomen.  Item 17 is a list of descriptors which attempt to 
explain the quality of the pain/discomfort associated with AMI symptoms.  These 
descriptors, or words used to describe the pain include, but are not limited to, tightness, 
stabbing, squeezing, tingling, and pressure.  This data was used for descriptive 
information only.  Item 18 is specific to symptoms other than chest pain/discomfort 
which may have been experienced.  This item includes 17 atypical symptom options from 
which the patients may choose.  These items of atypical symptoms or sensations include, 
but are not limited to, belching, vomiting, fainting, and generalized weakness.  Items 17 
and 18 also have an “other” choice option so patients could have described locations or 
symptoms which may have been experienced, but were not included in the list(s) given.  
This option was used for descriptive data only.  
Responses for each typical and atypical symptom were dichotomous; a “yes” 
response (meaning the symptom was experienced) was scored as “1” and a “no” response 
(meaning the symptom was not experienced) was scored as a “0”.  For analysis, total 
scores for summed typical and atypical symptoms were calculated for each participant.  
Higher scores indicate more typical and atypical symptoms experienced.  Determining 
the physical symptoms of AMI experienced by the patient is important as symptoms 
experienced may prompt the patient to seek or delay treatment (Lee et al., 2000).   
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Internal Influences 
Socio-demographic and Clinical Factors.  According to the CSM, illness 
representations are influenced by internal and external influencing sources which assist 
an individual in making sense of and coping with health and illness (Difenbach 
&Leventhal, 1996).  As stated, internal influences include socio-demographic factors and 
previous experience with health and illness.  Internal influences are conceptualized for 
this study as socio-demographic factors (age, gender, and race) and clinical factors 
(history of AMI).  
Socio-demographic factors (age, gender, and race) were collected using a 
researcher-developed Patient Characteristics Form (Appendix E).  This form will be 
discussed more in-depth at the end of this section.  Clinical factors (history of AMI) were 
collected using a researcher-developed AMI Clinical Data Extraction Form (Appendix 
F).  This form allowed the researcher to obtain only specific, pertinent medical 
information related to the AMI including presenting symptoms of AMI, history of DM, 
previous diagnosis of AMI, AMI location as identified on EKG, self-reported pain level 
on arrival (confirmed by self-report using the universal pain scale 0-10), and initial 
cardiac enzyme levels (troponin I and CK-MB).  Descriptive statistics (means and 
standard deviations, frequencies and/or percentages) were used to describe the sample. 
External Influences  
Personal Support.  External influences are conceptualized in this study as 
personal and professional support.  Evidence from previous studies indicates that being 
with a family member or other companion at the OS facilitates seeking timely treatment 
(Banks & Dracup, 2006; Gibler et al., 2002; Perry et al., 2001; Raczynski et al., 1999).  
Personal support was measured using Items 13, 14, and 15 from the MISS.  These 
  
57 
 
multiple-choice items specifically pertain to layperson support.  Item 13 asks the patient 
who she/he was with at the OS.  For statistical analyses, responses will be scored 
dichotomously and a response of “alone” will be assigned a “0” and all other responses, 
including responses such as a “spouse/partner”, “another family member”, “friend” or 
“co-worker”, will be assigned a “1”.  There is also an “other” choice for descriptive 
purposes.  Descriptive statistics were calculated to determine if participants were alone or 
with someone else at the OS.   
Item 14 pertains to the behavioral and emotional response(s) of laypersons to 
symptoms.  For coding and descriptive purposes, each response was initially assigned a 
number 1-9 to differentiate the responses.  For further statistical analyses, choices 
including, “suggested I get medical help”, “called EMS to get help for me” or “took me 
to the hospital” were scored as a “1”.  All other choices including, but not limited to, 
“they told me not to worry”, “they said or did nothing”, “they tried to comfort me”, were 
scored as a “0”.  The rationale for this scoring is that all other options besides, “suggested 
I get medical help”, “called EMS to get help for me”, or “took me to the hospital”, were 
choices which do not support seeking treatment in a timely manner.  Descriptive statistics 
were calculated to determine the behavioral and emotional response(s) of laypersons to 
symptoms. 
A researcher-developed single item (Item 15) was used to quantify the degree to 
which the layperson’s behavioral or emotional response was helpful in making the 
decision to seek treatment.  This item was rated on a five-point Likert scale scored from 
“1” (not at all helpful in making the decision to seek treatment) to “5” (extremely helpful 
in decision to seek treatment).  Higher scores indicate the layperson’s response was more 
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helpful in making the decision to seek treatment.  This single item was used to measure 
personal support (helpfulness of the layperson). 
Professional Support.  Professional support is specific to support received from 
HCPs including, but not limited to physicians, nurse practitioners (NPs), registered nurses 
(RNs), and physician assistants (PAs) or other licensed HCP.  It is of special interest to 
determine what AMI patients are advised to do in response to AMI symptoms by their 
HCP since this is a noted gap in the literature.  In addition, previous research 
demonstrates patients who contact a physician while experiencing AMI symptoms delay 
longer than those who do not attempt to contact a physician (Zerwic et al., 2003; Zerwic, 
personal communication, March, 4, 2011).  However, specific reasons for this delay are 
not discussed in the literature and it is unknown what AMI patients are advised and/or 
instructed to do by their HCP in response to AMI symptoms (Zerwic, personal 
communication, March 4, 2011).   
Professional support was measured using Item 23 from the MISS.  Patients were 
asked if they called a HCP after the OS, the time the HCP was called and the response 
from the HCP.  For coding purposes, the response, “did call a HCP” was coded “1”.  The 
response, “no, did not call a HCP” was coded as a “0”.  For coding purposes, all 
responses including, “call EMS” or “go to the hospital”, were coded as “1” and all other 
responses were given a “0”.  Descriptive statistics were calculated to report the action of 
calling a HCP after OS.   
Similar to the way professional support was measured, a researcher-developed 
single item (23a, part 1) was also used to quantify the degree to which the HCP’s 
response was helpful in making the decision to seek treatment.  This item was rated on a 
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five-point Likert scale scored from “1” (not at all helpful in making the decision to seek 
treatment) to “5” (extremely helpful in the decision to seek treatment).  Higher scores 
indicate the HCP’s response was more helpful in making the decision to seek treatment.  
Additional descriptive data was obtained using open-ended questions to determine the 
specific recommendations and/or instructions the HCP gave the patient.  
Cognitive Representations of Symptoms  
Identity and Cause: AMI Symptom Interpretation.  AMI symptom 
interpretation was measured using Item 8 from the MISS.  This item has a five-point 
Likert scale to measure symptom interpretation by being asked, “How similar were your 
symptoms with what you thought a heart attack would be like”?  This item was scored for 
statistical analysis from “1” (not at all similar with what you thought a heart attack would 
be like) to “5” (extremely similar to what you thought a heart attack would be like).  
Higher scores indicate actual symptoms were very similar to what the patient expected a 
“heart attack” experience would be like.  
Descriptive data regarding AMI symptom interpretation was collected using Items 
6, 7, 9, 10, 11, and 12 from the MISS.  Item 6 asks for a description of what patients were 
doing when symptoms started.  Item 7 is a multiple-choice item and patients were asked, 
“When you first noticed your symptoms, what did you think your symptoms were related 
to”?  Patients had to choose only one answer from the list of six possible responses (e.g. 
heart, indigestion, muscle pain, fatigue, dental problems, and stomach problems) to 
explain what they thought caused their symptoms.  For the purpose of statistical analyses, 
each response was initially assigned a number 1-6 to differentiate the responses.  For 
further statistical analyses, symptom interpretation (as related to the cause of symptoms) 
was measured as a dichotomous variable with “1” (symptoms being related to the heart) 
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and “0” (will be assigned to all other responses).  Descriptive statistics were calculated to 
determine the number of participants who thought their symptoms were or were not heart 
related.  
Items 9 and 10 ask for descriptive information regarding expectations about AMI 
symptoms versus the actual symptoms experienced.  Patients were asked, “What about 
their experience was similar (and not similar) with what they expected a heart attack to be 
like”?  These two items yield qualitative data only.  Items 11 and 12 were also used to 
collect descriptive data.  Item 11 asks the patient to describe if their symptoms started 
abruptly or gradually and in how many minutes their discomfort peaked.  Item 12 asks 
the patient to rate the intensity of the discomfort the patient experienced with their heart 
attack at the OS.  This was rated on the 0-10 Likert scale using the Universal Pain Scale. 
Controllability: Perceived Level of Control over AMI Symptoms.  Item 21 
from the MISS was used to gather descriptive data regarding perceived level of control 
over AMI symptoms.  Item 21 is a multiple-choice item that asks patients to give only 
one answer from a list of 12 possible choices (e.g. took medication, tried to relax, or 
called the emergency system) of what they did when they first noticed their AMI 
symptoms.  For coding purposes, each response was initially assigned a number 1-12 to 
differentiate the responses.  For further statistical analyses, choices including perceived 
level of control over symptoms were coded as a dichotomous variable.  Responses such 
as “called the emergency system, 911”, “went to the hospital”, “transported myself/had 
someone transport me to the hospital”, “drove to the doctor’s office/clinic” were assigned 
a value of “1” and all other choices will be assigned a “0”.  Descriptive statistics were 
obtained to determine what patients first did in response to AMI symptoms.  
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In addition, Item 22 was used to measure perceived level of control related to the 
overall symptoms experienced.  This item asks the patient to what degree he/she was able 
to control his/her symptoms.  Participants then rated their perceived ability to control 
their AMI symptoms on a five-point Likert scale.  This item was scored for analyses from 
“1” (not at all able to control their symptoms) to “5” (extremely able to control their 
symptoms).  Higher scores indicate more perceived control over the entire symptoms 
experienced.  
Timeline and Consequence: Perceived Level of Seriousness of AMI  
Symptoms 
Perceived level of seriousness of AMI symptoms were measured using four items 
from the MISS that reflect whether or not patients perceive symptoms experienced to be 
serious in nature (Items 20, 24, 25 and 26).  These items ask the patient to rate how 
serious they thought their overall symptoms were on a five-point Likert scale from “1” 
(not at all serious in nature) to “5” (extremely serious in nature).  Higher scores indicate 
higher perceived levels of seriousness.  Items were averaged for a total seriousness score 
for data analysis.  
Emotional Representations of Symptoms 
Anxiety.  Anxiety regarding AMI symptoms experienced was measured using the 
well-established Spielberger State-Trait Anxiety Inventory (STAI) (Spielberger, Gorsuch, 
& Lushene, 1970; Spielberger & Sydeman, 1994).  The state portion of the STAI consists 
of 20 items which measure the level of anxiety in response to a specific situation.  In this 
case, patients were asked to recall their feelings of anxiety at the time AMI symptoms 
were occurring.  The trait portion of the STAI consists of 20 questions to determine 
general anxiety levels of participants.  Examining the trait anxiety level was important as 
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anxiety is prevalent in those individuals who have a diagnosis of ischemic heart disease 
and having anxiety as a comorbidity may contribute negatively to patient outcomes 
(Doering et al., 2010).  Participants responded to items on a four-point Likert scale, with 
total scores ranging from 20-80 for each STAI component.  Higher scores on the STAI 
indicate higher levels of state and trait anxiety (Spielberger et al., 1970).  Although there 
are no specific cut-off scores that determine significant levels of anxiety in the STAI 
scoring manual, the recommended cut-off scores have been 39-40 in prior research 
studies (Kvaal, Macijauskiene, Engedal, & Laake, 2001; Kval, Ulstein, Nordhus, & 
Engedal, 2005).  For this study, scores greater than a cut-off score of 40 are indicative of 
high levels of anxiety for each components.  
Both of the self-report scales of the STAI have sound psychometric properties 
with reliability references supported with Cronbach’s alpha (α) values above 0.90 in 
previous studies relating to anxiety associated with AMI (Frazier et al, 2002; Lane, 
Corolla, Ring, Beevers, & Lip, 2001).  Construct validity for the STAI has also been 
previously supported (Lane et al., 2001; Spielberger et al., 1970) and this instrument has 
been used in previous research regarding AMI (Crowe, Runions, Ebbesen, Oldridge, & 
Streiner, 1996; Frazier et al., 2002; Garvin et al, 2002; Lane et al., 2001).  The STAI is 
the most commonly used measure of anxiety worldwide and is written at a sixth grade 
reading level, making it appropriate for participants with lower education levels 
(Spielberger et al., 1970; Spielberger & Reheiser, 2004; Spielberger & Sydeman, 1994).  
The STAI was purchased for use in this study. However, a copy of the STAI is not 
provided due to copyright laws.  
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Uncertainty.  Uncertainty regarding AMI symptoms was measured using the 
exhaustive list of experienced atypical and typical symptoms previously identified as by 
the patient.  In order to measure uncertainty regarding AMI symptoms, older adults were 
asked to rate their certainty that the symptom experienced was related to their heart. 
Higher scores indicate more certainty their overall symptoms were heart related. 
Participants were asked to rate certainty on a four-point Likert Scale with a rating from 
“1” (not at all sure the symptoms experienced were related to the heart) to a rating of “4” 
(100 % sure) that the symptom experienced was related to their heart.  Responses were 
averaged for a total symptom certainty score for data analysis.  Higher scores indicate 
patients were more certain the symptoms experienced were related to their heart.   
Participant Characteristics Form 
A structured researcher-developed socio-demographic questionnaire was created 
to not only characterize the participants of this study, but to obtain data regarding socio-
demographic factors which are conceptualized in this study as internal influences 
(Appendix E).  General socio-demographic data such as gender, age,  marital status, 
racial group, educational level (last grade completed), living arrangements, employment 
status, household income, and access to a telephone were collected during the interview 
process and/or using a review of the medical record with the participant’s permission as 
noted in the consent form.  As participants were 60 to 80 years of age and had access to 
Medicare, medical insurance information was not included in this questionnaire.  
AMI Clinical Data Extraction Form 
A Clinical Data Extraction form was created by the investigator in order to collect 
clinical data that was relevant to the interpretation of symptoms (Appendix F).  Only 
pertinent medical data was collected from the medical record which included presenting 
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symptoms of AMI, history of DM,  previous history AMI, AMI location as identified on 
EKG, self-reported pain level on arrival (confirmed by self-report using the universal 
pain scale 0-10), and initial cardiac enzyme levels (troponin I and CK-MB).  Participants 
gave permission to extract this information from the medical record in the consent form 
(Appendix G).  Only the specified clinical data was extracted.  
Coping Processes: Time to Seek Treatment 
Delay was determined using the time (measured in minutes) it took for the patient 
to seek treatment (delay time).  Delay time is defined as the time from the OS to 
presentation for treatment at the ED.  Time was computed in minutes from the OS to the 
time of arrival to the ED.  Delay time was dichotomized for group analysis into those in 
the shorter delay group of < 120 minutes and those in the longer delay group > 120 
minutes.  These time frames were chosen for their clinical relevance as the current 
national AHA (2012a) guidelines recommend appropriate medical interventions be 
administered within one hour of the OS for maximum reperfusion to occur.  However, 
this is problematic as very few individuals seek treatment within one hour after OS 
(Zerwic, personal communication, March 4, 2011).  As such, the two hour cut-off for the 
shorter delay group was chosen as a number of studies have pre-hospital delay times 
ranging from 1.4 to 6.4 hours (DeVon et al., 2008; Dracup et al., 2003; Gibler et al., 
2002; Goldberg et al., 2009; Kentsch et al., 2002; McKinley et al., 2000; Ottesen et al., 
2003; Perers et al., 2004; Popitean et al., 2005; Rasmussen et al., 2003; Taylor et al., 
2005; Thuresson et al., 2007; Ting et al., 2008; Zerwic et al., 2003). Furthermore, this 
cut-off time has been used in pervious larger, landmark studies (Gibler et al., 2002; 
Goldberg, 2009; Sacznyski et al., 2008). 
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Arrival time to the ED and the time of the OS was determined using the patient’s 
self-report and confirming this time using the medical record.  If there was a discrepancy 
between the times documented in the medical record and the patient’s self-report, the 
patient’s self-report was used to determine the delay time.  This has been done in similar 
research studies when discrepancies were noted (DeVon, Ryan, & Zerwic, 2004; Hwang 
et al., 2006; King & McGuire, 2007). It is important to note that there were very few 
discrepancies noted when determining delay time. 
Procedures 
After obtaining institutional review board (IRB) approval from appropriate sites, 
potential participants who met the specified inclusion criteria were identified.  The 
researcher attended a monthly nurse manager’s meeting at the hospital research site prior 
to the start of the study to explain the purpose of the study, the actual and potential risks 
and benefits of the study, as well as the researcher’s and participant’s responsibilities. 
This allowed time for any questions the nurse managers had regarding the research study. 
After this meeting, a nurse manager took the researcher to each applicable hospital unit 
and the researcher completed a short in-service on the research study and its process.  It 
was imperative that the staff, nurses, and nurse managers of the units had a thorough 
understanding of the study prior to its start.  Encouraging staff awareness and being 
respectful of the nursing and clinical staff helped to establish a strong rapport and led to a 
more successful data collection process.   
Hospitalized older adults were recruited for participation soon after admission and 
past the acute phase of the AMI from the intensive care unit (ICU), cardiac care unit 
(CCU), and cardiac step-down units.  After eligible participants were identified, the 
charge/primary nurse(s) confirmed that potential participants were pain free and 
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hemodynamically stable.  Referrals from hospital employees such as RNs or physicians 
were also used to identify prospective study participants.  After a stable condition was 
confirmed by stable vital signs and being free of chest pain/discomfort, the researcher 
invited eligible participants to take part in this study.  For the protection of human 
subjects, all participants gave a verbal and written informed consent prior to participation.  
If patients refused participation, no further contact was made.  
Data Collection  
At the hospital research site, the researcher collected data by in-person interviews 
to reduce the possibility of missing data.  In order to limit any personal bias during data 
collection, the investigator used the open and closed-ended questions from the 
questionnaires to guide the interview.  The questionnaires allowed for the patient to give 
a descriptive, narrative account of the events from the time of the OS until they accessed 
the healthcare system.  To avoid participant burden, it was estimated the interview would 
take approximately 60 minutes to complete.  However, an interview never lasted longer 
than 40 minutes.  
Protection of Human Subjects.  Appropriate IRB approval was obtained from 
Georgia State University (GSU) as well as PHC prior to the initiation of this study.  A 
verbal and written informed consent was given by each participant prior to participation.  
Full disclosure of the study included the study’s purpose, the actual and potential risks 
and benefits, the right to withdraw from the study at any time, and the researchers’ and 
participant’s responsibilities.  This consent form also included permission to obtain 
specific pertinent medical information from the medical record.  Participants received a 
written copy of the informed consent form (Appendix G).  Participants were also 
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reminded that participation was completely voluntary and he/she could withdraw from 
the study at any time without consequence.  
There were no known personal benefits for patients participating in this study.   
Participants did not have any more risks than they would in a normal day of life with the 
exception of inconvenience or fatigue with the interview process.  After the interview 
was completed, the researcher gave each participant a personalized, hand-written thank 
you note.  There was no incentive for participation.   
The researcher was aware that fatigue was a risk as it is one of the most 
commonly reported complaints by patients post-AMI (Brink, Karlson, & Hallberg, 2002; 
Crane, 2005).  To avoid participant fatigue and subsequent burden, an extensive time 
commitment for participation in this study was not expected.  Each interview was 
estimated to last no longer than 60 minutes and interviews could have been done in 
several sessions.  If patients had experienced fatigue or had a sudden onset of pain, the 
investigator would have returned at a later time to complete the interview, if permitted.  
However, this did not occur and no interviews had to be completed in sessions or at a 
later time.  
Confidentiality of all participants was carefully maintained throughout the 
research process, as no identifying information was noted on the data forms.  Instead, 
each participant was assigned an identification number (ID) which corresponded to 
his/her data.  All data collected was kept in a locked cabinet in the office of the 
investigator.  Only members of the research team (e.g. committee members and the 
statistician) had access to the data collected.  The record linking the participant’s ID and 
survey number was kept on a firewall and password protected computer separate from the 
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data file.  After the completion of the survey, data forms are being kept under lock and 
key for one year after which they will be destroyed by the researcher.   
Confidentiality was ensured by conducting interviews in a private hospital room.  
Patient safety was addressed as hospitalized AMI patients were not approached to 
participate until past the acute phase of the AMI.  Patients were also reminded that the 
decision whether or not to participate in this study had no impact upon his/her medical 
treatment and allowed time to ask questions concerning the research study. 
Overview of Data Analysis 
Prior to any type of data analysis and as per standards, missing data was identified 
and appropriate action was taken after the standard cleaning process.  Completed data 
were entered into Microsoft Access © and then transferred to Statistical Package for the 
Social Sciences (SPSS; Version 20.0)  and Predictive Analytics Software (PAWS; 
Version 18.0) by the investigator with the direction of a statistician.  The statistical 
significance level was set at p<.05 for this study.  Descriptive statistics were conducted 
on all data as appropriate to determine normality and to obtain sample characteristics. 
The analyses used for the study aims are as follows: 
Specific Aim 1: To examine how delay time was predicted by internal (age, 
gender, race, history of AMI) and external (personal and 
professional support) factors, and cognitive (symptom 
interpretation, perceived level of control, seriousness) and 
emotional (anxiety and uncertainty) representations of 
symptoms.   
Analysis approach:  A simultaneous multiple regression 
model was used to determine how delay time was predicted 
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by internal (age, gender, race, history of AMI) and external 
(personal and professional support) factors, and cognitive 
(symptom interpretation, perceived level of control, 
seriousness) and emotional (anxiety and uncertainty) 
representations of symptoms.  
Specific Aim 2: To examine the relationship of cognitive and emotional 
representations of symptoms on delay time and the 
contribution of external influencing sources (personal 
support).  
Analysis approach:  A binary logistic regression model was 
used for analysis wherein the covariates external influencing 
source (personal support) was entered into the model after 
other dependent variables.  
Specific Aim 3: To explore the differences in the level of personal support 
(helpfulness of laypersons) in making the decision to seek 
treatment between older adults who present for treatment in < 
120 minutes compared to those who delay > 120 minutes.   
Analysis approach:   An independent t-test was used to 
compare the two groups. This analysis was appropriate as the 
variable personal support (helpfulness of laypersons) was 
measured at the interval/ratio level of measurement.  
Specific Aim 4: To explore the differences in the level of professional support  
(helpfulness of healthcare professionals) in making the 
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decision to seek treatment between older adults who present 
for treatment in < 120 minutes compared to those who delay 
>120 minutes.   
Analysis approach:  The independent t-test equivalent, the 
Mann-Whitney U was used to compare the two groups. This 
analysis was appropriate as the variable personal support 
(helpfulness of healthcare professionals) was not normally 
distributed.  Descriptive data about specific recommendations 
or instructions the healthcare professional gave the patient 
was also collected.  
Specific Aim 5: To explore the differences in cognitive representation of 
identity/cause (AMI symptom interpretation) between older 
adults who present for treatment in < 120 minutes compared 
to those who delay > 120 minutes.    
Analysis approach:  An independent t-test was be used to 
compare the two groups. This analysis was appropriate as the 
variable cognitive representation of identity/cause (AMI 
symptom interpretation) was measured at the interval/ratio 
level of measurement.  Descriptive data  was also collected 
regarding what the patients thought was the cause of 
symptoms, what they were doing at OS, as well as their 
expectations about AMI symptoms and the actual symptoms 
experienced.   
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Specific Aim 6: To explore the differences in the level of cognitive 
representation of controllability (perceived control over AMI 
symptoms) between older adults who present for treatment in 
< 120 minutes hours compared to those who delay > 120 
minutes. 
Analysis approach:  An independent t-test was used to 
compare the two groups.  This analysis was appropriate as 
the variable cognitive representation of controllability was 
measured at the interval/ratio level of measurement.   
Specific Aim 7: To explore the differences in the cognitive representation of 
timeline/consequence (perceived seriousness of AMI 
symptoms) between older adults who present for treatment in 
< 120 minutes compared to those who delay > 120 minutes. 
Analysis approach: An independent t-test was used to 
compare the two groups.  An average total seriousness score 
was calculated for analysis.  This analysis is appropriate as 
the variable cognitive representation of timeline/consequence 
(perceived seriousness of AMI symptoms) was measured at 
the interval/ratio level of measurement.   
Specific Aim 8: To explore the differences in the emotional representation of 
anxiety regarding AMI symptoms between older adults who 
present for treatment in < 120 minutes compared to those 
who delay > 120 minutes.   
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Analysis approach:  An independent t-test was used to 
compare the two groups.  This analysis was appropriate as 
the variable emotional representation of anxiety regarding 
AMI symptoms was measured at the interval/ratio level of 
measurement.  
Specific Aim 9: To explore the differences in the emotional representations of 
uncertainty regarding AMI symptoms between older adults 
who present for treatment in < 120 minutes compared to 
those who delay > 120 minutes.   
Analysis approach:  An independent t-test was used to 
compare the two groups.  An average total uncertainty score 
was calculated to use for analysis.  This analysis was 
appropriate as the variable emotional representations of 
uncertainty regarding AMI symptoms were measured at the 
interval/ratio level of measurement.   
Research Questions: 
1. What are the coping processes (symptom management strategies) used in 
an attempt to control or cure AMI symptoms by older adults?  
Analysis approach:  Descriptive data was collected concerning what 
specific strategies participants used in an attempt to control or cure their 
AMI symptoms.  
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2. What is the relationship of initial cardiac enzyme levels (troponin I and 
CK-MB) to patient’s perceptions of the cognitive representations of 
seriousness of their AMI symptoms? 
Analysis approach: The variables cardiac enzymes and perceptions of 
seriousness were measured at the interval/ratio level of measurement.  To 
measure the strength of this relationship between these two variables, a 
Pearson product-moment correlation coefficient was calculated.   
Summary 
The study used a descriptive, cross-sectional, comparative design to examine the 
differences between two groups of older adults diagnosed with AMI.  A non-random 
sample of hospitalized older adults was recruited.  The research setting for this study was 
one private acute care, hospital in the metro-Atlanta area of Georgia.  Data were collected 
in person using a semi-structured interview technique.  Descriptive statistics and other 
statistical analyses including multiple regression, logistic regression, independent t-tests 
(or the non-parametric equivalent) and/or chi-square statistics, as appropriate were 
conducted to address study aims and research questions.   
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CHAPTER IV 
RESULTS 
 
The results of this descriptive, comparative, cross-sectional study of the factors 
that influence treatment seeking delay among older adults diagnosed with AMI are 
presented in this chapter.  A summary of the characteristics of the sample with 
comparison of delay groups, hypothesis testing, and research questions are reported.  
There were 178 potential participants screened for eligibility from September 
2011 through March 2012 at one acute care hospital in the metro Atlanta, GA area.  Of 
these older adults, 46.1% (n=82) met eligibility criteria and agreed to participate.  Most 
potential participants were excluded based on the required age criteria.  There were four 
patients who met eligibility criteria, but refused to participate in the study, resulting in a 
95% participation rate.  The reasons given for refusal to participate included, “can’t do it 
now, my family is here”, “too anxious; been through too much” and “ready to go home”.  
One patient refused and stated, “I didn’t have a heart attack” and believed he should not 
be considered for an interview.  One participant was withdrawn from the study by the 
investigator after completing a portion of the interview.  During the interview, this older 
adult showed signs of cognitive impairment which was an exclusion criterion for the 
study.  When potential participants refused, no further contact was made.  
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Data Screening Procedures and Description of Major Study Variables 
Prior to data analysis procedures and as recommended by Field (2009), all data 
have undergone the standard cleaning process including an inspection for errors in data 
entry as well as identification of any missing values.  Descriptive statistics were 
examined to determine normality for major study variables at the interval/ratio level and 
frequencies were calculated for all categorical variables.  All variables were normally 
distributed with the exception of delay time.  Delay time was positively skewed as there 
were three outliers regarding delay time in minutes.  These three participants delayed 
seeking treatment greater than two weeks (more than 20,000 minutes after the OS).  In 
order to test the overall integrity of the simultaneous multiple regression model, the 
regression analyses for specific aims one and two were conducted with and without the 
outliers.  The regression results were similar and the overall integrity of the model held 
with the same predictors retained. As such, the original regression results with outliers 
included are reported.   
For subsequent analyses, the delay time was dichotomized into two groups based 
on a clinically relevant time frame.  Those in the shorter delay group (delayed ≤ 120 
minutes from OS) were coded as 0 and those in the longer delay group (delayed > 120 
minutes) were coded as 1.  For analyses comparing the two groups, the outliers were 
retained in the group delaying > 120 minutes.  PAWS (Version 18.0) and SPSS (Version 
20.0) software packages for statistical analysis were used and the statistical significance 
level was set a p< .05 for all analyses, unless otherwise noted.   
Reliability of Instruments  
The main questionnaire used to collect a majority of the data for this study was 
the MISS.  No one tool provided a complete picture of the AMI experience, therefore 
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the MISS was created by combining two well-established instruments (Banks & Dracup, 
2006; Dracup & Moser, 1997; Dracup et al., 2003; Hwang et al., 2006; Khraim et al., 
2009; Khraim et al., 2010; Lesneski, 2009; McKinley et al., 2000; Noureddine et al., 
2008; Zerwic et al., 2003).  The MISS is a descriptive tool which consists of yes/no 
questions, Likert-type items, and open-ended questions which elicit a short answer 
response.  This instrument is descriptive and does not yield a cumulative score therefore, 
reliability testing was not appropriate. Content validity was presented in the discussion 
of instruments in Chapter 3. 
Reliability testing was calculated for the state and trait portions of the STAI.  
The Cronbach’s alpha coefficients for both scales state and trait scales were adequate 
(α=.87 and α=.81, respectively).   
Characteristics of the Sample 
A summary of the sample characteristics of the total sample (n=82) and the two 
delay groups is presented in Table 1.  The shorter delay group (delaying ≤ 120 minutes) 
consisted of 40 participants (52.4%) while 42 participants (47.6%) comprised the longer 
delay group (delayed > 120 minutes).  The age range of the total sample was 60-80 years 
of age (M=69, SD=5.8).  The majority of participants were retired/unemployed White 
men (n=69; 82.9%) who were married (n=59; 73.2%).  Most of these older adults lived 
in a home which they owned (n=75; 91.5%) with their spouse/significant other (n=59; 
73.2 %), were high school graduates (n=27; 32.9%) or completed some college or 
technical school (n=23; 28.1%).   
Chi-square statistics or independent t-tests, as appropriate, were conducted to 
determine if there were any differences between the shorter delay group (delaying ≤ 120 
minutes) and the longer delay group (delayed > 120 minutes).  There were no significant 
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differences in age, gender, marital status, race, education level, employment status, 
living arrangements, and annual household income between the two delay groups (Table 
1).  To compare delay groups on income, the income variable was collapsed into three 
categories for analysis (0=prefer not to answer, 1=below $60,000 and 2=above $60,000).  
All the income categories are also presented in Table 1.  Forty-six percent of the sample 
preferred not to answer the question regarding income.  
The mean score of state anxiety for the total sample was high (Table 3).  The 
mean cut-off scores for both state and trait anxiety scales is 40; scores above 40 indicate 
clinically significant high levels of anxiety (Kvaal et al., 2001; Kvaal et al., 2005).  The 
mean state anxiety score for the participants who were asked to recall their level of 
anxiety during the AMI symptom experience was 56.47 (SD=10.37) with a range of 33-
80.  The mean trait anxiety levels for the total group were below the cut-off point for 
high trait anxiety (Table 3).  The STAI measures two distinct concepts (state and trait). 
The correlations between state and trait anxiety was r=.365, p=.002.  The amount of 
variance is 13% indicating that, although there is overlap, the concepts are sufficiently 
independent for both to be included in analyses. 
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Table 1 
Sample Characteristics of Older Adults Diagnosed with AMI with Comparison of 
Delay Groups 
  
Characteristic                         Total Sample            Short Delay           Long Delay          χ2 or          p 
           (n=82)                     (n=40)                 (n=42)                t test        value 
M(SD) or n (%)     M(SD) or n (%) M(SD) or n (%)   
Age 69 (5.8) 70.13(5.8) 67.98 (5.7) -1.68 .097 
Gender  
                                 Male 
    Female 
 
52 (63.4%) 
30 (36.6%) 
 
22 (55%) 
18 (45%) 
 
30 (28.6%)  
12 (71.4%) 
 
2.4 
 
.120 
Marital Status 
                      Married/SO 
 Widowed          
          Sep/Divorce/Single 
59 (72.0%) 
12 (14.6%) 
 
11(13.4%) 
31 (77.5%) 
4 (10%) 
 
5 (12.5%) 
28 (66.7%) 
8   (19%) 
 
6 (14.3%) 
1.5 .466 
Racial Group  
                               White 
    Minority 
 
68 (82.9%) 
14 (17.1%) 
 
34 (85%) 
6 (15%) 
 
34 (81%) 
8 (19%) 
 
 
.23 
 
.636 
Education Level 
           Some High School 
GED/High School 
Graduate 
Some College/    
      Tech School 
College Graduate  
    Graduate Degree 
 
 12 (14.6%) 
27(32.9%) 
 
23 (28.1%) 
14 (17.1%) 
6 (7.3%) 
 
  7(17.5%) 
12 (30%) 
 
9  
(22.5%) 7  
(17.5%) 5  
(12.5%) 
 
    5 (11.9%) 
15 (35.7%) 
 
 
14 (33.3%) 
7 (16.7%) 
1 (2.4%) 
 
 
   4.4 
 
 
.358 
 
Employment Status 
     Working FT (>35hr/wk) 
Working PT (<35 hr/wk) 
Retired/     
    Unemployed 
Disabled 
 
  13 (7.9%) 
7 (8.5%) 
53 (64.6%) 
 
9 (11%) 
 
    4 (10%) 
4 (10%) 
30 (75%) 
 
2 (5%) 
 
9 (21.4%) 
3 (7.1%) 
23 (54.8%) 
 
7 (16.7%) 
 
 
5.58 
 
.123 
Lives with 
                       Spouse/SO 
Alone 
Friend/Family 
 
56 (68.3%) 
14 (17.1%) 
12 (14.6%) 
 
31 (77.5%)          
  7 (17.5%)          
  2 (5%) 
 
25 (59.5%)           
   7 (16.7%)        
 10 (23.8%) 
 
 
5.93 
 
 
.052 
 
Annual Household 
Income   
            Less than $21,000 
 $21,000- $40,999 
$41,000-$60,999 
$61,000-$81,999              
  $81,000-$100,999 
Above $101,000 
 
 
 5 (6.1%) 
4 (4.9%) 
5 (6.1%) 
16 (19.5%) 
4 (4.9%) 
10 (12.2%) 
   
 
3.92 
 
 
.271 
Note.
 a 
Shorter delay < 120 minutes, Longer delay > 120= minutes.
 
 
 b 
n=44 
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Clinical Data for Total Sample and Delay Groups 
A summary of the clinical data relevant to the AMI experience for the total 
sample and the two delay groups is presented in Table 2.  The majority of older adults 
(n=54; 65.9%) in this sample experienced a non-ST elevation MI (NSTEMI) while 
(n=28; 34.1%) experienced an ST elevation MI (STEMI).  Prior to the interview, (n=63; 
76.8%) of older adults had some type of post-AMI medical intervention.  The most 
common medical intervention post AMI was percutaneous coronary intervention (PCI) 
which may or may not have included stent placement.  Other post-AMI medical 
interventions included CABG, IABP, and one participant had a cardiac viability study to 
determine damage to the myocardium.  The descriptive statistics for all post-AMI 
medical interventions are also presented (Table 2).  
Over 40% of the older adults (n=33; 40.2%) had a diagnosis of diabetes mellitus 
(Type I or Type II) and (n=30; 36.6%) had experienced a previous MI (STEMI or 
NSTEMI).  Older adults were also asked about their pain level on arrival to the ED 
using a rating of zero to ten (Universal Pain Scale) with higher numbers indicating 
higher pain levels.  The mean older adults’ self-reported pain level on arrival to the ED 
was high (M=7.1, SD=3.4) with 69.5% (n=57) reporting a pain level of six or higher. 
Although most participants reported high pain levels, few (n=8; 9.8%) participants 
reported no pain at all (Table 2).     
Although the AHA recommends activating EMS at the OS and being transported 
to the hospital via ambulance, a large majority (n=51; 62.2%) of these participants 
arrived to the ED by private occupancy vehicle (POV).  About half of the sample (n=42; 
51.2%) had no previous episode of symptoms prior to their MI diagnosis, while the other 
half of the sample (n=40; 48.8%) had more than one episode of symptoms prior to this 
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hospital admission.  Fifty-four (53.6%) participants reported being asleep, watching 
television or doing “nothing” at the OS.  These findings indicate the majority of this 
sample of older adults was not physically active at the OS (Table 2). 
Descriptive data was also obtained regarding where participants were and what 
they were doing at the OS, as well as how similar their symptoms related to what that 
they thought a heart attack would be like.  Seventy-three percent (n=60) of all 
participants were at home, 14.6% (n=12) were in a public place, and 78% (n=64) were 
with someone else at the OS.  When asked how similar their symptoms were with what 
they thought a heart attack would be like, 47.5% (n=39) participants responded, “not at 
all” or “mildly similar” to what a heart attack would be like, while only 13.4% (n=11) 
responded, “extremely similar” to what a heart attack would be like.   
Chi-square statistics, independent t-tests, or the non-parametic t-test equivalent, 
the Mann-Whitney U, as appropriate, were conducted to determine if there was any 
significant difference between delay groups on selected clinical data relevant to the AMI 
experience.  There were no significant differences between groups with the exception of 
history of AMI and troponin levels.  Older adults in the shorter delay group (n=19; 
47.5%) were significantly more likely to have a history of an AMI when compared to 
the longer delay group (n=11; 26.2%), [χ2 (1)=4.01, p=.045].  Similarly, those in the 
longer delay group had significantly higher Troponin-I levels than those in the shorter 
delay group (U=541, z =-2.48, p=.013).  See Table 2.  
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Table 2  
 
Older Adults’ Clinical Data Relevant to the AMI Experience 
 
Characteristic                    Total Sample 
        (n=82) 
  M(SD) or n (%) 
     Short Delay       
        (n=40)           
  M(SD) or n (%) 
   Long Delay      χ2 or t        p 
      (n=42) 
M(SD) or n (%) 
  
MI Classification        
                                NSTEMI 
STEMI 
 
54 (65.9%) 
28 (34.1%) 
 
29 (72.5%)   
11 (27.5%) 
 
   25 (59.5%)         1.53      .215             
   17 (40.5%) 
Medical Intervention 
                                         Yes 
No 
 
63 (76.8%) 
19 (23.2%) 
 
10 (25%) 
30 (75%) 
 
    9 (21.4%)         0.15      .702 
  33 (78.6%) 
Type of Medical Intervention 
                                          
PCI 
CABG 
IABP 
PCI and IABP 
Cardiac Viability Study 
None at time of interview 
 
55 (67.1%) 
4 (4.9%) 
2 (2.4%) 
2 (2.4%) 
1 (1.2%) 
18 (22% ) 
  
Co-Morbidity 
                            Previous MI 
 Diabetes Mellitus 
 
 
30 (36.6%) 
33 (40.2%) 
 
19 (47.5%) 
13 (32.5%)  
 
   11 (26.2%)        4.0       .045* 
   20 (47.6%)        1.97     .16 
 
Mode of Transportation to ER 
                                        POV 
                                        EMS 
 
 
 
51 (62.2%) 
31 (37.8%) 
 
 
24 (60%) 
16 (40%) 
 
 
27 (64.3%)          0.16      .689 
15 (35.7%) 
 Troponin Levela 
 
7.61(19.28) 33.74      46.62            -2.48      .013* 
 CK-MB Levelb 
 
43.56(87.19) 13.77      19.69            -1.75      .079 
 Pain Level Onset Sympt. 
0 
1-5 
6-10  
6.25 (3.36) 
8 (9.8%) 
26 (31.8%) 
47 (57.4%) 
6.35 (3.42) 
 
6.15 (3.34)        -0.27       .787 
 
 Pain Level ED Arrival               
0                                                                 
1-5  
6-10 
7.1 (3.4) 
8 (9.8%)
15 (19.5%) 
57 (69.5%) 
7.41(3.04) 6.73 (3.73)        -0.89       .38 
 Attributed Symptoms to 
                              Indigestion   
Heart                                   
Muscular Pain                             
Breathing Problem                      
Flu/Fatigue                                   
“Didn’t know”                             
Other                                            
 
28 (34.1%) 
17 (20.7%)
12 (14.6%) 
11 (13.4%) 
3 (3.6%)
2 (2.4%) 
6 (7.2%)
  
Doing at OS 
Exercising 
Sleeping 
Sitting/watching TV 
Nothing 
Working 
Eating 
Other 
 
18 (22.0%) 
17 (20.7%) 
17 (20.7%) 
10 (12.2%) 
5 (6.1%) 
5 6.1%) 
10 (12.7%) 
  
Note. a M (SD) reported for the total sample, mean rank and z score reported for delay groups. b  n=33.  M 
(SD) reported for total sample, mean rank and z score reported for delay groups. * p<.05 
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         Table 3 presents descriptive statistics of the variables measured using the 
theoretical concepts of the adapted CSM for the total sample with a comparison of the 
two delay groups.  Furthermore, the statistical analyses such as chi-square, independent 
t-tests or the Mann Whitney U results as appropriate, are also provided.  
Table 3 
Descriptive Statistics of Theoretical Variables with Comparison of Delay Groups  
Variable n=82 
M(SD) 
Short Delay 
n=40 
M(SD) 
Long Delay 
n=42 
M(SD) 
 χ2 t or z        p 
Delay time   
    (minutes) 
1938.44 (4584.3) 75.20 (28.57) 3712.95 (5908.75) 3.99 <.001* 
Total AMI  
Symptoms 
   Typical      
   Symptoms 
   Atypical    
   Symptoms 
8.67 (3.86) 
4.04 (2.36) 
4.63 (2.69) 
8.75 (3.56) 
4.35 (2.28) 
4.40 (2.38) 
8.60 (4.16) 
3.74 (2.42) 
4.86 (2.96) 
0.18 
1.18 
0.77 
.857 
.242 
.444 
Overall Symptom    
   Certaintya  
2.20 (0.97) 2.76 (0.85) 1.66 (0.76) 6.20  .001* 
Certainty Typical  
    Symptoms 
9.76 (7.00) 13.43(7.24) 6.26 (4.62) 5.31  .001* 
Certainty Atypical    
   Symptoms 
9.09 (6.37) 10.45 (6.28) 7.79 (6.26) 1.92     .058 
Personal Support 3.80 (1.38) 4.26 (0.891) 3.36 (1.597) 3.08 .003* 
Professional 
Support b 
2.71 (1.61) 9.67 8.86 0.20     .843 
Perceived Control 
of Symptoms 
1.63 (0.97) 1.36 (0.87) 1.88 (0.99) 2.50 .014* 
Perceived 
Seriousness of 
Symptoms 
3.39 (1.38) 3.88 (1.24) 2.93 (1.35) 3.30 .001* 
State Anxiety 56.47(10.37) 55.94 (11.11) 56.95 (9.78) 0.41     .684 
Trait Anxiety 37.13 (9.47) 36.77 (9.02) 37.47 (10.00) 0.31     .757 
a Certainty scores higher numbers = more certainty symptoms were related to heart; b n=17, Mean rank and z score are 
reported. *p<.05 
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Aims Testing 
Cognitive Representations of Symptoms on Delay Time.  Using the Common 
Sense Model (CSM) framework as a guide, a simultaneous multiple regression analysis 
was used to examine how delay time was predicted by internal (age, gender, race, 
history of AMI) and external (personal and professional support) factors, and cognitive 
(symptom interpretation, perceived level of control, seriousness) and emotional (anxiety 
and uncertainty) representations of symptoms (Aim 1).  Due to the exploratory nature of 
this study, the original data analysis plan was to enter all the theoretical variables into 
the model and determine which variables added a significant amount to the variance in 
the time to seek treatment (delay time).  However, due to the large number of theoretical 
variables relative to the sample size, and in order to create a more parsimonious model, 
correlations with theoretical variables relative to delay time in minutes were examined. 
Those that had correlations that were significant at p< .10 were the only theoretical 
variables included in the model.  All theoretical variables were non-significant at this 
level with the exception of personal support (helpfulness of the layperson) (r=-.41, 
p<.001), perceived seriousness of AMI symptoms (r=-.33, p=.002), and the total number 
of typical AMI symptoms (r=-.21, p=0.058).  Also included were the demographic and 
clinical characteristics that differed between the groups at the p< 10 level including age, 
the binary version of living status (living alone or with someone), and history of MI.  
See Table 4.  
When these variables (age, living status, history of MI, personal support, 
perceived seriousness of AMI symptoms, and total number of typical AMI symptoms) 
were entered into the simultaneous regression model, the full model was significant 
(R
2
=.23F (6, 68)=3.44, p=.006) and explained 23% (R
2
) of the variance in delay time.  
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The only significant independent predictor of time to seek treatment was 
personal support (perceived helpfulness from laypersons).  A higher level of personal 
support from laypersons` was associated with decreased delay time for this sample of 
older adults (Table 4).  
Table 4 
Multiple Regression Analysis Results for the Variables Predicting Time to Seek 
Treatment (n=75) 
 
a
 Sym= Total Number of Typical Symptoms 
b 
Binary version of living status was coded 
as living alone (0), with someone (1). * p<.05  
 
Factors Associated with Shorter versus Longer Delay Groups.  The 
relationship of cognitive (total number of AMI symptoms, perceived seriousness, 
perceived control) and emotional representations (anxiety and uncertainty) on delay time 
based on clinically relevant time frames, and the contribution of external influencing 
sources, personal support (helpfulness of laypersons) was examined (Aim 2).  The 
original data analysis plan was to also determine the contribution of professional support 
(the helpfulness of the HCP).  However, given the low number of older adults in this 
sample who sought professional support (n=17), this variable was not included in the 
analysis as it was not a large enough number to conduct reliable statistical testing.  Also 
included in the model with the theoretical variables were the demographic and clinical 
Variable B                     SE      β         p 
Constant 
Personal Support 
Perceived Seriousness  
Number of Typical Sym
a 
Age 
Living Status
b 
History of MI 
 7280.60           6943.15 
-1142.43            400.74 
- 621.01             404.11 
- 219.99             234.40 
  -31.34                93.50 
  268.49            1446.28          
- 873.61           1084.45 
   
     -.330 
     -.184 
     -.104 
         .039 
         .021 
        -.089 
       
    .006* 
    .129 
    .351 
    .739 
    .853 
    .423 
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characteristics that differed between the groups at the p<.10 level including age, the 
binary version of living status (living alone or with someone), and history of MI.   
To examine Aim 2, a binary logistic regression using a hierarchal procedure was 
done.  The two delay groups were used as the dependent variables (0= shorter delay 
group; presentation < 120 minutes and 1= longer delay group; presentation >120 
minutes).  The cognitive representations (total number of AMI symptoms, perceived 
seriousness, and perceived control) and emotional representations (anxiety and 
uncertainty), and selected sample characteristics (age, living status, and history of MI) 
were entered in Step 1.  Personal support (helpfulness of the layperson) was entered in 
Step 2 and it did not contribute significantly (p =0.48) to the predictive power of the 
model.  However, the total model remained significant and Nagelkerke’s R2 of 0.56 
indicated a moderately strong relationship between prediction and the grouping of delay 
groups.  Prediction success overall was 80% (77% for the shorter delay group and 82% 
for the longer delay group).  The Wald criterion demonstrated that only certainty of AMI 
symptoms made a significant contribution to the prediction of delay group.  The odds 
ratio (OR) indicated that participants who were more certain their symptoms were heart 
related had higher odds of being in the shorter delay group (sought treatment sooner) 
than the participants who were less certain their symptoms were heart related (delayed 
seeking treatment. See Table 5.     
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Table 5 
Logistic Regression Results for the Variables Predicting Time to Seek Treatment (n= 75) 
 
Note. *p<.001 
   
Exploratory Differences between Delay Groups.  An independent t-test or 
non-parametric equivalent was used to explore the differences in the level of personal 
support and professional support in making the decision to seek treatment between delay 
groups (Aim 3 & 4).  Those in the shorter delay group perceived significantly higher 
personal support from laypersons than those in the longer delay group (Table 3). 
Because of the small proportion of participants who sought advice from professionals 
(21%; n=17), the Mann-Whitney U was used to examine differences between the two 
delay groups for professional support (helpfulness of the HCP).  There was no 
significant difference in the level of professional support in making the decision to seek 
Variables     B (SE)        OR      95% CI                  p 
Step 1 
Constant 
Number of Symptoms 
Perceived Control 
Perceived Seriousness 
State Anxiety 
Certainty 
Age 
Living Status 
History of MI 
 
Step 2 
Constant 
Number of Symptoms 
Perceived Control 
Perceived Seriousness 
State Anxiety 
Certainty 
Age  
Living Status 
History of MI 
Personal Support 
 
 9.84 (5.51)  
-0.08 (0.12) 
 0.47 (0.42) 
-0.36 (0.31) 
 0.04 (0.04) 
-1.67 (0.45) 
  -.12 (0.07) 
  0.77 (1.05) 
  -.18 (0.87) 
 
 
 9.51 (5.49) 
-0.78 (0.12) 
 0.50 (0.41) 
-0.33 (0.32) 
 0.05 (0.04) 
-1.58 (0.47) 
-0.10 (0.68) 
 0.48 (1.10) 
-0.04 (0.92) 
-0.24 (0.33) 
 
        
0.92 
1.60 
0.69 
1.05 
0.19 
0.90 
2.15 
0.83 
 
 
 
0.93 
1.64 
0.72 
1.05 
0.21 
0.91 
1.62 
0.96 
0.79 
                              
 
  0.72- 1.16            0.471 
  0.71- 3.63            0.261 
  0.38- 1.28            0.241 
  0.98- 1.12            0.206 
  0.07- 0.46            0.001* 
  0.79-1.03             0.122 
  0.28-16.72           0.464 
  0.15- 4.50            0.832 
    
    
 
   0.73-1.18           0.525 
   0.72-3.74           0.236 
   0.39-1.34           0.302 
   0.98-1.13           0.187 
   0.08-0.51           0.001* 
   0.79-1.04           0.146 
   0.19-13.99         0.664 
   0.16-5.70           0.964 
0.41-1.52      0.480 
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treatment between delay groups (Table 3). Of those older adults who contacted a HCP 
about their symptoms (n=17), 82% (n=13) were in the longer delay group and 18% 
(n=4) were in the shorter delay group.  Further analyses done using Chi square showed a 
significant association with delay groups and whether they contacted their HCP (X 
2(1)=8.320, p =.004) indicating calling a HCP was associated with being in the longer 
delay group.  
Older adults were also asked about the specific recommendations or instructions 
which were given to them when contacting a HCP (Table 6).  Only three of the 
seventeen participants volunteered that they specifically spoke with a nurse and only one 
participant specifically recalled talking to a physician.  The recommendations from the 
HCPs varied.  When they spoke with a nurse, two participants were given an 
appointment later that same day and one participant was only told by the nurse to “keep 
a watch” on his chest pain.  The one participant who spoke with a physician states he 
was advised to come in that day for an evaluation.  No participants were told by their 
HCP to call 911 as per AHA recommended guidelines (AHA, 2012b).   
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Table 6 
 
 
An independent t-test was used to explore the differences in AMI symptom 
interpretation (total number of symptoms experienced), differences in perceived control 
of symptoms and perceived seriousness of symptoms between delay groups (Aim 5, 6, 
& 7).  See Table 3.  The total number of AMI symptoms experienced did not differ 
significantly different between delay groups.  Additional analyses were performed to 
determine if there were any differences in the self-reported pain levels at the time of OS, 
as well as the pain level on arrival to the ED.  There were no significant differences 
between the delay groups on the pain levels (Table 3).  There was however, a significant 
difference between groups on perceived control and perceived seriousness of symptoms. 
Those in the shorter delay group perceived significantly less control over their 
Frequencies of Responses of the Healthcare Provider (n=17) 
 
Responses of HCP       n   
 
Told to come to office and then sent to 
ER from office 
 
6 
 
 
 
 
Told to go to Hospital by HCP 
 
3 
 
 
 
 
Made Appointment for Later that Day                    
 
2 
 
 
 
 
 
No Answer/Never Called Back 
 
2 
 
 
 
 
Told it was My Nerves 
 
1 
 
 
 
 
Told Could Not Be Seen Today 
 
1 
 
 
 
 
Told “Keep a Watch on it” 
 
 
1 
 
 
 
Mentioned it when presented for another 
complaint, no recommendation given 
1   
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symptoms and perceived their AMI symptoms as significantly more serious than those 
in the longer delay group (Table 3).  
Emotional Representations.  Comparison of differences between delay groups 
on state and trait anxiety levels and uncertainty over symptoms were examined using an 
independent t-test (Aim 8 & 9).  There were no significant differences between delay 
groups for state or trait anxiety levels (see Table 3).  In order to measure uncertainty 
regarding AMI symptoms, older adults were asked to rate their certainty that the 
symptom experienced was related to their heart.  Higher scores indicate more certainty 
that their overall symptoms were heart related.  Those in the shorter delay group were 
more certain their overall symptoms were heart related (Table 3).  Further analysis was 
done to examine certainty regarding typical and atypical symptoms.  Those in the shorter 
delay group had higher scores indicating more certainty regarding typical symptoms 
than those in the longer delay group (Table 3).  Although certainty regarding atypical 
symptoms was not significant at the set alpha level of p<0.05, there was a trend toward 
significance (p=0.058) (Table 3).  This trend suggests that those who are more certain 
their symptoms are heart related seek treatment sooner than those who do not.  This 
finding has been reported in previous studies (Kentsch et al., 2002; McKinley et al., 
2000; Pattenden et al., 2002; Taylor et al., 2005; Zapka, 2000).  
Research Questions 
To gain further knowledge on control over AMI symptoms, all older adults were 
asked specific open-ended questions concerning what they first did at the OS and the 
specific symptom management strategies used in an attempt to control or cure AMI 
symptoms (Research Question 1).  The three most common responses when participants 
were asked what they first did at the OS were: tried to relax (29.3%; n=24), told 
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someone (24.4%; n=20), or did nothing (11%; n=9).  Participants were also asked about 
the degree the specific strategies used in an attempt to control/cure their symptoms were 
helpful.  In regards to the degree of helpfulness, over half of the sample (52%) stopped 
the activity they were doing, but the majority (50%) reported that stopping did not 
relieve their symptoms or they were unsure if it relieved their symptoms.  Other 
common strategies such as taking a medication or lying down to rest did not help relieve 
symptoms for a majority of participants.  The most common strategies and how helpful 
they were are presented in Table 7. 
Table 7 
Frequencies for Common Coping Processes and Responses in an Attempt to 
Control/Cure AMI Symptoms *(n=82) 
 
Strategy n (%) Yes, helped 
symptoms 
Did not help 
symptoms 
Unsure if it 
helped 
Stopped What They 
Were Doing 
43 (52.4%) 2 (2.4%) 37 (45.1%) 4 (4.9%) 
Took Medication 
   ASA/Pain Med     
   Antacid 
   Nitro 
 
39 (47.5%) 
25 (30.5%) 
15 (18.3%) 
 
7 (8.5%) 
    3 (3.7%) 
9 (11%) 
 
 20 (24.4%) 
 17 (20.7%) 
  5 (6.1%) 
 
12 (14.6%) 
  5 (6.1%) 
  1 (1.2%) 
Lie Down/Rest 37 (45.1%) 6 (7.3%) 24 (29.3%)   7 (8.5%) 
Deep Breathing 24 (29.2%)         0 (0) 22 (26.8%) 2 (2.4%) 
Stand/Sit Quietly 19 (23.2%) 3 (3.7%) 12 (14.6%) 4 (4.9%) 
Belching 15 (18.3%) 1 (1.2%) 10 12.2%)     4 (4.9%) 
Note. *Could have more than one strategy. 
To determine if there was a relationship of cardiac enzyme levels to seriousness 
of AMI symptoms, a bivariate correlational analysis was done (Research Question 2). 
There was no significant relationship between initial cardiac enzyme levels [troponin I 
(r=.011, p=.92), CK-MB (r=.074, p=.51)] and the perceived level of seriousness of 
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symptoms.  However, since there was a significant difference between the delay groups 
based on the level of perceived seriousness of symptoms, additional analyses using non-
parametric statistics were performed.  The Mann-Whitney U was used to detect group 
differences.  This analysis was chosen because troponin-I levels were not normally 
distributed and since CK-MB levels were no longer routinely ordered at the recruitment 
site, only 40.3% (n=33) of the total sample had a documented CK-MB level.  
There were no differences in the CK-MB levels between the shorter delay group 
and the longer delay group.  There was however, a significant difference between groups 
in the Troponin-I levels; those in the longer delay group had significantly higher 
Troponin-I levels than those in the shorter delay group.  This would be an expected 
clinical finding as Troponin-I levels peak in 4 to 24 hours and can remain elevated for 
up to 3 weeks after myocardial injury.  See Table 2. 
Summary 
This chapter presented the results of this descriptive, cross-sectional study of the 
factors that influence treatment seeking delay among older adults diagnosed with AMI.  
A thorough description of the characteristics of this sample of older adults was described 
and results from data analyses were reported.  Although exploratory analysis was 
conducted using chi-square, independent t-tests (or its non-parametric equivalent) on a 
number of variables, to avoid a Type I error, the multiple and logistic regressions were 
conducted and are the sophisticated analyses in understanding the variables that 
contribute to delay in seeking treatment. 
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CHAPTER V 
 
DISCUSSION AND CONCLUSIONS 
 
This chapter discusses findings and conclusions from this study in relation to the 
current literature.  These conclusions address the strengths and limitations of this study, 
as well as the implications for nursing practice.  Recommendations for future research 
studies are also identified. 
Discussion  
Although this study aimed at the AMI experience of older adults 60-80 years of 
age, the mean age for this sample was 69.04 which reflects an older population.  Since 
the average age for individuals with first time AMI is 64.5 years for men and 70.3 years 
for women and the risk for CHD rises sharply at age 60 (AHA, 2009) the decision was 
made to include individuals with ages ranging from 60-80 years.  Although all efforts 
were made to adequately represent both genders, a greater proportion of men participated 
in this study (63.4 %) which is consistent across previous studies.  Only three studies 
reviewed had near equal numbers of men and women participants (DeVon et al., 2010; 
King & McGuire, 2007; Moser et al., 2005).  
This study is unique from prior studies as only older adults within a specific age 
range were enrolled.  Other investigations included a median or mean age consistent with 
an older population (age>60), however when examining the clinical characteristics of 
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the samples of these studies,  a majority reported  wide age ranges (DeVon et al., 2010; 
DeVon et al., 2008; Gibler et al., 2002; Kentsch et al., 2002; McKinley et al., 2000; 
Perers et al., 2004; Rasmussen et al., 2003; Saczynski et al., 2008; Thuresson et al., 2007; 
Zerwic et al., 2003).  The largest age range noted in studies reviewed was from 24 to 97 
years or age (DeVon et al., 2008).  Other studies reviewed had a focus of older adults, but 
only in comparison to younger age groups (Popitean et al., 2005; Ting et al., 2008).  
Studies with the exclusive focus on older age groups remain limited even though changes 
in demographics over the past several decades indicate patients hospitalized for AMI 
were older in age and had a higher number of co-morbidities (Floyd et al., 2009). 
Furthermore, older adults also have higher mortality rates than younger age groups as 
81% of deaths related to CHD in the US occur in those greater than 65 years of age 
(AHA, 2011) making them a particularly vulnerable group.  These population shifts are 
projected to rise as the US population continues to add to its aging population.  This 
indicates a need for additional future research with a focus on older adults with a 
diagnosis of AMI.  
Consistent with prior studies, this study found a median delay time of 2.6 hours 
demonstrating pre-hospital delay remains problematic for those with AMI symptoms.  
Earlier studies regarding seeking treatment for AMI symptoms have noted mean or 
median delay times ranging from 1.4 to 6.4 hours (DeVon et al., 2010; DeVon et al., 
2008; Gibler et al., 2002; Goldberg et al., 2009; Kentsch et al., 2002; McKinley et al., 
2000; Perers et al., 2004; Popitean et al., 2005; Rasmussen et al., 2003; Saczynski et al., 
2008; Taylor et al., 2005; Thuresson et al., 2007; Ting et al., 2008; Zerwic, et al., 2003).  
However, comparing the current study across the previously mentioned global studies on 
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delay is difficult because as mentioned, few have a specific age ranges which focus on 
older adults (Goldberg et al., 2009; Ottesen et al., 2003).  
The symptom experience for this sample included an average of eight AMI 
symptoms (typical and atypical) with high levels of pain and high anxiety at the time of 
the event.  However, there were no significant differences between the delay groups in 
the number of symptoms experienced, pain, or anxiety levels at the time of the event.  
Being able to accurately interpret the meaning of these symptoms is essential for guiding 
the appropriate action, to seek timely treatment.  There were also no significant 
differences between groups by gender as noted in prior research.  However, only 36% of 
the total sample was comprised of women.  Conceivably, with a larger number of women 
participants, there may have been differences between the groups as it is noted in the  
literature that female gender is an independent socio-demographic factor which is 
significantly associated with increased delay time (Blohm et al., 1998; Finnegan et al., 
2000; Gibler et al., 2002; Johansson, et al., 2004; Moser et al., 2006; O’Donnell et al., 
2006; Perers et al., 2004; Shin et al., 2010; Ting et al., 2008). 
There was a significant difference between groups in the Troponin-I levels; those 
in the longer delay group had significantly higher Troponin-I levels than those in the 
shorter delay group (Table 2).  However, this is an expected clinical finding as Troponin-
I levels peak in 4-24 hours and can remain elevated for up to a week after myocardial 
injury (Porth, 2006).  This reveals physiological evidence that older adults in the longer 
delay group were farther along in their AMI experience when compared to the shorter 
delay group and with increased Troponin-I levels, there was more likely more damage to 
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the heart muscle.  This in turn suggests that overall outcomes would be less than optimal 
for those in the current study who were in the longer delay group. 
Consistent with the CSM, which was chosen to guide the study design, being 
more certain that symptoms were related to the heart was significantly associated with 
being a member of the shorter delay group (< 120 minutes to seek treatment).  These 
findings are consistent with evidence from other research in which participants who 
recognize their symptoms are heart related seek treatment sooner than those who attribute 
symptoms to less serious causes (Finnegan et al., 2000; Horne et al., 2000; Hwang et al., 
2006; Johansson et al., 2004; King & McGuire, 2007; Lovelin et al., 2007; Moser et al., 
2005; Zerwic et al., 2003).  
Further analyses regarding certainty of symptoms provide results indicating 
participants had more certainty about their typical AMI symptoms being heart related 
when compared to their atypical symptoms.  This is consistent with current studies as 
atypical AMI symptoms have been previously identified as an influencing factor that 
increases the time to seek treatment (Albarran et al., 2007; Arslanian-Engoren, 2005; 
Kimble et al., 2003; McSweeney et al., 2001; McSweeney et al., 2003; Ottesen et al., 
2003; Schoenberg et al., 2003a; Zerwic, 1999).  Being unable to associate atypical AMI 
symptoms to the heart increases one’s risk for a delay in seeking timely medical 
treatment.  This is especially important for older adults as it may be more difficult for 
them to discern between age-related physical changes, the effects of certain co-
morbidities, and the symptoms of AMI (Hwang, et al., 2006; Johansson et al., 2004; 
Kentsch et al., 2002; Schoenberg et al., 2003a).  In order to address the challenges 
regarding certainty of AMI symptoms, HCPs, insurers, and community-based health 
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organizations should conduct educational sessions for older adults describing typical and 
atypical AMI symptoms prior to their occurrence.  It is also necessary for nurses and 
other HCPs to stress the benefits of timely medical treatment for AMI symptoms.  
Educational sessions specific to older adults must include significant others in the event 
that symptoms occur when they are together with the patient.  Along these same lines, it 
would be beneficial to caution patients who are at high risk such as those with a cardiac 
history, against using symptom management strategies which may add to the delay to 
seek treatment.  
HCPs or those who are giving advice or instructions over the phone should be 
given specific guidelines or instructions on how to respond to older adults who are calling 
for medical advice as it pertains to typical or atypical AMI symptoms.  When providing 
advice by phone, patients with AMI typical and atypical symptoms must be instructed to 
activate EMS per the current AHA guidelines (2012b).  Of the few (21%) participants 
who contacted a HCP for advice on their symptoms, none were instructed to activate 
EMS.  However, there may be several explanations of why participants were not 
instructed to do so.  First, older adults in this sample may have diminished the 
implications of their symptoms when contacting a HCP for advice.  Second, if HCPs 
were familiar with the patient calling, he/she may have attempted to prevent a hospital 
admission by treating the patient’s symptoms by telephone or having the patient come 
into the office.  Future research should explore whether attempting to prevent admission 
or treating the patient by telephone has any impact on the older adult’s health outcomes.  
Participants did not activate EMS on their own behalf either as over half of the 
sample (62%) reported they presented to the ED using a private vehicle.  An explanation 
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why so few participants in this sample contacted EMS is that they may not have realized 
or understood the advantages of ambulance transport or thought using their own vehicle 
would have been faster.  This is contrary to current AHA guidelines (2012b) which assert 
that if symptoms persist, individuals should wait no more than five minutes to activate 
EMS.  Older adults with AMI symptoms are a true medical emergency and must be 
educated they are not being alarmists when they call for help.  The AHA (2012b) 
emphasizes patients should feel entitled to activate EMS for assistance and older adults 
should be reminded that using EMS is the only means by which they can be rapidly 
evaluated and receive treatment en route to the hospital (Garvey, MacLeod, Sopko, & 
Hand, 2006).  
A discrepancy between expected AMI symptoms and actual symptoms 
experienced has been noted to be a cause of delay in seeking treatment (Hwang et al., 
2006; Johansson et al., 2004; Lovelin et al., 2007; Moser et al., 2005; Zerwic et al., 
2003).  These findings are supported by the current study.  For example, 45.7% of 
participants reported that they thought their AMI symptoms were “not at all” or “mildly 
similar” to what they expected a heart attack would be like.  Only one-fifth (20.7%) of 
participants believed their symptoms were heart related while one-third (34.1%) of these 
older adults believed their symptoms were related to indigestion or some other stomach 
problem.   
It is interesting to note that that the majority of participants were at rest when their 
symptoms began and about half described their symptoms as a gradual onset.  This could 
be a possible explanation for the discrepancy between expected and actual symptoms 
experienced for this sample.  A gradual onset of symptoms which progressed slowly may 
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have been unexpected as it is not representative of how an AMI is portrayed in print and 
social media (Moser et al., 2006).  This is further evidence that older adults have 
difficulty interpreting AMI symptoms and provides support for the need of the previously 
mentioned educational sessions.  
In the context of the CSM, individuals’ actions are based on their cognitive 
representations or thoughts in response to a health threat.  These cognitive representations 
are based on the physical manifestation of the illness (symptoms), previous experience 
with these symptoms, as well as the likely causes of illness.  Slightly more than one-third 
of older adults in the sample had a previous AMI, and in the context of the CSM, the 
previous symptom experience should help the individual to form a more accurate 
representation of the symptoms when they are experienced again.  This is supported with 
the results of this study as the delay time for those who had a previous AMI was 
significantly less than those without a history of AMI.  Findings from other studies are 
inconsistent when examining if those with a previous AMI sought treatment sooner.  
Some studies show individuals with a history of AMI sought treatment significantly 
sooner than those without a previous MI (Gibler et al., 2002; Khraim et al., 2009; 
Perkins-Porras et al., 2009) while others found individuals with a previous AMI delayed 
longer than those without a previous AMI (Blohm et al., 1998; Goff et al., 1999; 
McKinley et al., 2000; Rosenfeld, 2004).  Other researchers have shown that medical 
history had no significant influence on delay time (Dracup et al., 2003; Johansson et al., 
2004; Song et al., 2010).  As findings are conflicting, additional research is needed in this 
area to understand how an individual’s prior AMI experience may influence their 
decision to seek treatment with subsequent MIs.  Nonetheless, it is necessary to educate 
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older adults that subsequent AMIs may or may not be the exact experience.  This may 
explain the conflicting findings noted in previous research and demonstrates a need for 
additional inquiry and thorough educational sessions on the interpretation of typical and 
atypical AMI symptoms. 
When examining factors associated with delay in time (in minutes) to seek 
treatment, having personal support (perceiving laypersons as helpful) was significantly 
associated with less delay time.  Laypersons’ helpfulness in the decision to seek treatment 
is consistent with previous studies in which being with someone else at the onset of AMI 
symptoms facilitated seeking treatment (Banks & Dracup, 2006; Gibler et al., 2002; 
Kentsch et al., 2002; Lesneski, 2009; Perry, et al., 2001; Raczynski et al., 1999; 
Thuresson et al., 2007).  Having some type of personal support by being in the company 
of a layperson (friend, family and/or co-worker) may help one in placing the symptoms in 
a more accurate representation of the health threat (Waller, 2006).  The role of laypersons 
in influencing one’s decision to seek treatment in a timely manner also has been 
recognized with other illnesses in which symptoms may be difficult to interpret such as 
stroke and heart failure (Friedman & Quinn, 2008; Zerwic et al., 2007).  Regardless of 
the disease context, evidence suggests that the role of the layperson influences the 
decision to seek treatment.  
Although living status (living alone or with someone) was not statistically 
significantly different between the delay groups, there was a trend toward significance   
(p=.052).  Results from this study and other prior studies (Banks & Dracup, 2006; Gibler 
et al., 2002; Kentsch et al., 2002; Lesneski, 2009; Perry, et al., 2001; Raczynski et al., 
1999; Schoenberg et al., 2003a; Thuresson et al., 2007) demonstrate whether someone 
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else is present at the time of the AMI event is an important factor for decreasing delay 
time.  In this sample, most of the older adults lived with someone; their symptoms began 
at home, and they were with others when their symptoms began.  Living with or being 
with someone makes it easier to confer about their symptoms.  In contrast, for those who 
are alone when symptoms begin, their cognitive or mental representation of AMI 
symptoms is likely to be more difficult since they do not have others with which to 
confer. Subsequently, this may add to a delay time (Banks & Dracup, 2006; Horne et al., 
2000).  
It is important that the previously recommended educational sessions for older 
adults stress the important role of laypersons in the decision to seek treatment.  Older 
adults and their significant others need to be well-informed about the value of having a 
specific action plan if and when symptoms occur.  This plan should include 
administration of aspirin, nitrates (if applicable), and activation of EMS (AHA, 2012b).  
Although the helpfulness of a layperson was associated with less time to seek 
treatment, seeking assistance from a HCP was not.  While the numbers of older adults 
who contacted their HCP was small in this study (21%), a significantly higher percentage 
of those who contacted their HCP were in the longer delay group (82%).  A number of 
previous studies support the premise that contacting a HCP for advice on AMI symptoms 
adds to an increased delay time (Gibler et al., 2002; Hwang et al., 2006; Johansson et al., 
2004; King & McGuire, 2007; Leslie et al., 2000; O’Donnell, et al., 2006).  HCP 
contributions to delay time are also recognized within the stroke literature (Moser et al., 
2006; Mosley, Nicoli, Donnan & Dewey, 2011; Srivastava & Prasad, 2001).  Although 
the disease process of stroke and AMI are very different, both are acute health issues 
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which require timely medical intervention.  In practice, it is imperative that nurses and 
other HCPs recognize that they play a vital role in preventing delay in seeking treatment 
regardless of the health issue.   
For this sample, interactions when contacting an HCP included phone calls, going 
to the office for an exam, or making appointments for a later time or date.  It is unknown 
who answered the phone and may have given advice/recommendations to the few in this 
sample who contacted an HCP.  In many physician offices, the individuals who answer 
the phone are not likely to be physicians, registered nurses, or physician assistants, but 
rather nursing assistants or other unlicensed personnel. This may greatly affect the 
responses that the patient or family member would receive.  It is crucial that patients ask 
to speak to licensed HCPs when calling for advice or recommendations by phone.  The 
messages that these participants in this sample received from HCPs suggest that all 
HCPs, particularly those in physicians’ offices, must be able to recognize both typical 
and atypical symptoms of AMI and should immediately refer patients for an emergency 
assessment instead of suggesting they be seen at a later date or time.       
If patients were told to go to their HCP office for an exam, it makes sense that 
those patients would have longer delay times than those who went directly to the ED for 
treatment.  Another explanation for the prolonged delay when contacting a HCP may be 
that patients were unable to reach their HCP on the first attempt and may have waited for 
a return telephone call.  It may also be plausible that HCPs were unable to conclude the 
cause of or recognize the serious nature of the patient’s symptoms simply speaking by 
telephone.  Regardless of the scenarios, any calls to HCPs that include typical and/or 
atypical AMI symptoms should result in a directive for the patient to immediately seek 
  
102 
 
 
emergency services, thus decreasing delays in treatment time and possibly improving 
patient outcomes (Moser et al., 2006).  Failing to recognize the serious nature of 
symptoms and not advising patients to activate EMS indicates an urgent need for 
improvement in the specific knowledge of symptoms and the consistent response of 
HCPs per current AHA guidelines (Moser et al., 2006).    
A large portion of the sample did initially try to self-manage their AMI 
symptoms.  Fifty percent of the sample, however, did not receive relief from their self-
management efforts and their symptoms continued.  Helping older adults understand that 
the continuation of symptoms after efforts to self-manage should move them to action.  
According to the CSM, the fact that efforts to relieve symptoms did not work as they had 
in the past (e.g. treating indigestion with an antacid and it resolving) should cue patients 
that this is a different symptom experience and influence them to consider different 
causes of the symptoms.  This might result in taking different action such as seeking help 
to interpret symptoms with input from others or seeking medical treatment.  This was not 
the case in this sample; even with continuing symptoms, older adults delayed seeking 
treatment.   
According to the CSM, the emotional representation of anxiety is thought to 
affect decision making.  As stated earlier, participants in this study had high levels of 
state anxiety at the time of OS; however, the participants’ anxiety level at the time of OS 
was not significantly associated with delay time.  Nonetheless, high anxiety regarding 
AMI symptoms has been identified as a significant predictor of reduced delay time in 
other studies (Khraim et al., 2009; McKinley et al., 2000; Moser et al., 2005).   
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Study Strengths 
There are several strengths in this study.  First, this study used the well-
established CSM to guide the study design.  This theoretical framework has been used 
extensively in previous research to understand how individuals perceive, manage and 
cope with a broad range of illnesses, including AMI symptoms (Dracup et al., 2009; 
Dracup et al., 1995; Fowler et al., 2007; Goff et al., 1999; Hagger & Orbell, 2003; 
Harralson, 2007; Kapstein, et al., 2007; Kelly et al., 2005; King & McGuire, 2007; 
McAndrew et al., 2008; McKinley et al., 2000; Meischke et al., 2006; Meischke et al., 
1999; O’Neill, 2002; Ryan & Zerwic, 2003; Tullman et al., 2007; Zerwic, 1998, 1999; 
Zerwic, et al., 1997; 2003).     
Second, few studies focus solely on older populations (Alexander et al., 2005; 
Dodd et al., 2011; Halon, Adawi, Dobrecky-Mery & Lewis, 2004) even though their risk 
for AMI is higher and overall prognosis is worse for those older than age 65 than younger 
populations (Dodd et al., 2011; Hwang et al., 2006; Maheshwari et al., 2000; Popitean et 
al., 2005; Ryan & Zerwic, 2003).  Third, interviews were collected in person soon after 
the AMI experience which helped limit recall bias and the possibility of missing data. 
Finally, all participants had a diagnosis of an AMI confirmed in the medical record by 
classic electrocardiogram changes (EKG) and/or abnormal cardiac bio-markers such as 
elevated cardiac enzymes (troponin I and CK-MB).  Unlike previous studies (Banks & 
Malone, 2005; Rasmussen et al., 2003) patients with chest pain or acute coronary 
syndrome without a diagnosis of AMI were excluded from this study.  
Study Limitations 
Although there are strengths, there are also limitations of this study.  Participants 
made up a small, non-random sample consisting primarily of White men from one acute-
  
104 
 
 
care facility in a major southern city, thus limiting the generalizability of the study 
findings.  This study only includes those who survived their AMI experience and does 
not capture delay for those older adults who never sought treatment for their AMI 
symptoms or who did not survive their AMI.  
This study could be strengthened by more in-depth follow-up related to whom 
participants spoke with when contacting a HCP.  Few participants recalled specifically 
speaking with a nurse or a physician when they contacted a HCP and it remains unknown 
if they spoke with unlicensed or non-healthcare personnel when attempting to contact 
their HCP.  In future studies, asking participants specifically to whom they spoke would 
be helpful in explaining the recommendation or instructions they were given by phone. 
Although only a small subset of this sample contacted a HCP, this is still important as 
contacting a HCP was significantly associated with a longer delay time and was not 
helpful for these older adults.  
Although all efforts were made to interview participants soon after their AMI, 
recall bias may have influenced the accuracy of the participant’s retrospective account of 
their AMI experience.  However, retrospective accounts of the AMI experience soon after 
the event helps to reduce recall bias and this has been a successful method in similar 
studies (Banks & Dracup, 2006; Dracup et al., 2003; Johansson et al., 2004; Khraim et 
al., 2010; Lesneski, 2009; Moser et al., 2005; Noureddine et al., 2008; Rasmussen et al., 
2003; Zerwic et al., 2003; Zerwic, personal communication, March 4, 2011).   
Implications for Nursing Practice 
Many participants attempted to relieve their symptoms.  Symptom management 
strategies used in an attempt to cure or control AMI symptoms included, but were not 
limited to; stopping the activity they were doing, taking medication, lying down, and 
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deep breathing techniques. Interestingly, over half of the sample (52%) stopped the 
activity they were doing, but the majority (50%) reported that stopping did not relieve 
their symptoms or they were unsure if it relieved their symptoms.  Other common 
strategies such as taking a medication or lying down to rest did not help relieve 
symptoms either for a majority of participants.  Current AHA guidelines (2012b) suggest 
that not obtaining relief from symptoms within a five minute window from the OS 
provides evidence that symptoms may be heart related and require immediate attention by 
a HCP.  These guidelines need to be more prominent in the general public’s education 
about AMI symptoms.  Along these same lines, there should be more emphasis on 
atypical symptoms by HCPs.  As stated, educational sessions are needed to assist older 
adults and significant others to more accurately recognize atypical AMI symptoms and 
subsequently, take action to seek timely treatment.  As laypersons were found to be 
helpful in decreasing delay times, HCPs should emphasize this education to the general 
public as well.  By doing so, laypersons may also be able to more readily recognize 
symptoms and follow a plan of action when their loved one experiences AMI symptoms. 
Although much has been stated about the responsibility of education as it related 
to nurses and other HCPs, it is important to broaden the scope of responsibility as heart 
disease is a significant public health problem.  Responsibilities for the education efforts 
of older adults must also be expanded.  This expansion should include public and private 
insurance establishments, religious organizations, assistive living/long term care 
facilities, public healthcare clinics, hospitals, and other group settings who have the 
capabilities to create and distribute educational DVDs, online modules, and/or booklets 
on individual AMI risk assessments and information regarding expectations regarding 
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typical and atypical AMI symptoms.  Educational materials should also include a step by 
step action plan in response to symptoms.  Items should be disseminated to older adults 
and their significant others, including adult children.  Reaching the adult children of older 
adults is imperative as they may be an influencing source on the decision to seek 
treatment (Schoenberg et al., 2003a).  In return for participation, older adults could be 
offered wellness incentives.  For example, an incentive would allow for lower insurance 
premiums.  These educational efforts must be long-term programs as previous 
interventions which have little to moderate impact have been short-term (Goldberg, et al., 
2009; Saczynski et al., 2008).  This kind of long-term and general educational efforts 
would reach many and has the potential to reduce mortality and morbidity associated 
with the delay associated with AMI (Vavouranakis, 2010).  
Recommendations for Future Research 
This study focused on older adults who are at a higher risk for mortality and are 
shown to delay seeking treatment for AMI symptoms to a greater extent when compared 
to other age groups.  Findings from this study need to be replicated using a larger, more 
diverse sample of older adults.  As few older adults activated EMS by calling 911 for 
transport after the OS, future research, namely intervention studies (e.g. community-
based educational programs) should focus on ways to increase the use of EMS especially 
for high risk groups such as older adults who are particularly vulnerable to increased 
delay times.   
Chest pain is the most self-recognizable symptom of AMI and the model for the 
‘Hollywood heart attack’ which characterizes the symptoms of an AMI as beginning 
abruptly, being intense, and immediately debilitating.  Health education for older adults 
and their significant others needs to emphasize the more accurate representation of AMI 
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symptoms which typically have a gradual onset and may progress slowly (Moser et al., 
2006; National Heart, Lung, & Blood Institute, 2011).  For example, older adults need to 
be informed that symptoms can occur even at rest as found in this sample of older adults.  
Intervention studies that also focus on the management of calls to HCPs would be helpful 
in assuring that elders are directed to emergency assessment for symptoms of an AMI. 
Although it provided a good guide related to the overall AMI symptom 
experience, most of the variables in the CSM did not significantly contribute to delay in 
this sample of older adults.  As such, future research should focus on other possible 
factors which may be related to time to seek treatment.  
Contacting a HCP was associated with an increased delay even though only a few 
participants in this study did so.  One of the reasons for this delay given by the 
investigator was that HCPs may have been attempting to prevent an admission to the 
hospital by treating the patient’s symptoms by telephone or in the office.  Although the 
role of the HCP in delay needs to be examined more closely, future research may 
examine if attempting to prevent hospital admission or treating the patient by telephone 
had any impact on patient outcomes.  In order to prevent prolonged delay in the future, 
there should be an emergency number for every HCP office wherein a knowledgeable 
and licensed HCP would talk with the patient about symptoms, early treatment options, 
and empower them to activate EMS per current guidelines.  
Conclusion 
Delay in seeking treatment in the life threatening event of an AMI continues to be 
a global phenomenon.  Reasons people delay seeking treatment are complex and multi-
dimensional and include, but are not limited to, misinterpretation of AMI symptoms, 
trying to self-manage symptoms even without subsequent relief, and not having others to 
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confer with about symptoms.  More public health campaigns to help dispel the myths of 
the ‘Hollywood heart attack’ and that reflect a more progressive onset of symptoms may 
help reduce delay. Getting that message out to lay persons of all ages is essential as 
laypersons were helpful in reducing delay time for this sample. 
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Appendix A 
Overview of Theoretical Concepts, Variables to be Measured, Instrument Item and Plan for Scoring 
Theoretical 
Concepts 
Variable to be 
Measured 
 Instrument Item 
(Items are from the 
MISS unless otherwise 
noted)  
Scoring Type of Scale  Possible 
Range 
Interpretation 
Health Threat Physical 
Symptoms of 
AMI 
Items 16: Typical 
Symptoms  
 
 
 
 
Item 17: Description of 
Type of Pain 
 
 
 
 
Item 18: Atypical 
Symptoms  
 
16: Total 
number of 
typical 
symptoms were 
summed. 
 
 
 
17: Descriptive 
 
 
 
 
 
18: Total 
number of 
atypical 
symptoms were 
summed. 
16: 22 Items 
1-4 Likert 
Scale 
 
 
 
 
17: 0= no 
      1= yes    
+ open ended 
‘other’ option. 
 
 
18: Items 1-4 
Likert Scale 
(17-68  + other 
‘option’) 
16: 0-22 
 
 
 
 
 
17: 
Descriptive 
data only 
 
 
 
 
18: 0-18 
16: Higher scores 
indicate the more 
typical and atypical 
symptoms 
experienced. 
 
 
 17: Descriptive 
purposes to describe 
type of pain 
 
 
 
18: Higher scores 
indicate the more 
atypical symptoms 
experienced. 
Internal 
Influencing 
Sources 
Socio-
demographic 
Factors  
(age, gender, 
race)  
 
 
 
Researcher-developed 
Patient Characteristics 
Form. 
 
 
 
 
 
   Descriptive statistics 
will be used to 
describe the sample as 
a whole and then by 
delay groups. 
Shorter delay group          
(<120 minutes) 
Longer delay group   
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Clinical Factors 
(history of 
AMI)  
 
 
 
Researcher-developed  
AMI Clinical Data 
Extraction Form. 
.  
(>120 minutes). 
 
Descriptive statistics 
will be used to 
describe the medical 
history  
of the sample as a 
whole and then by 
delay groups. 
External 
Influencing 
Sources 
Personal 
Support of 
Laypersons 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Item 13: Alone at OS  
 
 
 
 
 
 
 
 
 
 
Item 14: Layperson 
Response at OS 
 
 
 
 
 
 
 
 
 
 
Researcher-developed 
item 15: Degree of 
Layperson Helpfulness 
 
13: Descriptive 
 
 
 
 
 
 
 
 
 
 
14: Descriptive 
 
 
 
 
 
 
 
 
 
 
 
15: Likert Scale 
 
 
 
 
 
 
 
 
 
 
 
 
 
0= all other 
layperson 
responses 
excluding 
called EMS or 
took to 
hospital 
1= called EMS 
or took to 
hospital. 
 
 
 
15: 1 item  
1-5 Likert 
Scale 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
15: 1-5 
 
 
 
 
13: The number & 
percentages will be 
calculated to 
determine the number 
of participants who 
were alone or with 
someone else at the 
OS.   
 
 
 
 
14: The number & 
percentages will be 
calculated to 
determine how 
layperson responded 
at OS. 
 
 
 
 
 
 
15: A Mean 
Layperson helpfulness 
score will be 
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Professional 
Support of HCP 
 
 
 
 
 
 
 
 
 
 
 
 
 
Item 23 part 2  
 
 
 
 
 
 
Researcher- developed 
item  
23 (a. part 1): HCP 
Helpfulness 
 Descriptive data 
regarding the time the 
HCP was called and 
recommendations the 
HCP gave the patient 
will be obtained. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
23 part 2: 
Descriptive 
 
 
 
 
 
23 (a. part 1): 
Likert Scale 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
23 (a. part 1) 
1 item  
1-5 Likert 
Scale 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
23 (a. part 
1) 
1-5 
 
calculated. Higher 
scores indicate the 
layperson’s response 
was more helpful in 
making the decision 
to seek treatment. 
Independent t-tests 
will be done to detect 
differences between 
groups.   
 
 
 
 
The number & 
percentages will be 
calculated to 
determine the number 
of participants who 
called their HCP.  
 
 
A Mean HCP 
helpfulness score will 
be calculated. Higher 
scores indicate the 
HCP’s response was 
more helpful in 
making the decision 
to seek treatment. 
Independent t-tests 
will be done to detect 
differences between 
groups.  
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Cognitive 
Representations 
      
Identity and 
Cause 
AMI Symptom 
Interpretation 
Item 6: Activity at OS 
 
 
 
 
 
 
 
 
Item 7: Attribute of 
Problem 
 
 
 
 
 
Item 8:Expected versus 
experienced symptoms 
 
 
9, 10: Description of 
how symptom 
experience was or was 
not similar to 
expectations of MI 
symptoms.  
 
 
 
Item 11: Description of 
how quickly symptoms 
started 
 
6: Descriptive 
 
 
 
 
 
 
 
 
7: Descriptive 
 
 
 
 
 
 
8: Likert Scale 
 
 
 
Qualitative Data 
 
 
 
 
 
 
 
11: Descriptive 
 
 
 
 
6: Investigator 
systematically 
grouped 
responses into 
categories.  
 
 
 
 
 
 
 
 
 
 
 
8: 1-5 Likert 
Scale 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
8: 1-5 
 
 
 
 
 
 
6: The number & 
percentages will be 
calculated to 
determine what 
participants were 
doing at OS. 
  
 
 
 
7: Number & 
percentages will be 
calculated to 
determine what 
participants thought 
their symptoms were 
related to.  
 
 
Higher scores 
indicated actual 
symptoms were very 
similar to what the 
participant expected a 
heart attack would be. 
 
 
 
 
11: The number & 
percentages will be 
calculated to 
determine how 
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Item 12: Pain Scale at 
OS 
 
12: Descriptive 
 
 
 
 
 
 
quickly symptoms 
started.  
12:  A Mean pain 
score will be 
calculated. Higher 
scores indicate higher 
levels of pain at the 
OS. Independent t-
tests will be done to 
detect differences 
between groups.   
        
Controllability  
Perceived Level 
of Control over 
AMI Symptoms 
Item 19: Strategies 
Item 21: What 
participants first did at 
OS.  
  
 
 
 
Item 22: Perceived 
control over symptoms 
 
  
 
19: Descriptive 
21:Descriptive 
 
 
 
 
 
 
22: Likert scale 
 
 
 
 
 
 
 
 
22: 1-5 Likert 
scale  
 
 
 
 
 
 
 
 
 
22:1-5 
 
1, 21: Number & 
percentages will be 
calculated to 
determine strategies 
used to control/cure 
symptoms and the 
first thing participants 
did at OS. 
 
22: Higher scores 
indicate more control 
over the entire 
symptoms. 
Independent t-tests 
will be done to detect 
differences between 
groups.  
 
Timeline & 
Consequence 
Perceived  
Seriousness of  
AMI Symptoms  
 
Items 20: Perceived 
seriousness of 
symptoms 
 
  
 
20: Likert Scale 20: 1-5 Likert 
Scale 
20: 1-5 20: Higher scores 
indicate higher levels 
of perceived 
seriousness of 
symptoms. 
Independent t-tests 
will be done to detect 
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differences between 
groups.   
Emotional 
Representations 
      
 Anxiety 
Regarding AMI 
Symptoms 
 
 
 
Uncertainty 
Regarding AMI 
Symptoms 
State-Trait Anxiety 
Inventory (STAI) of the 
Spielberger State-Trait 
Anxiety Inventory.  
 
 
Researcher developed 
uncertainty ratings for 
each typical or atypical 
symptom identified as 
experienced.  
 
SAI: Likert 
Scale 
 
 
 
 
 
Uncertainty: 
Likert Scale 
SAI: 1-4 
 
 
 
 
 
 
Uncertainty:   
1-4 Likert 
Scale 
SAI: 20-80 
 
 
 
 
 
 
Uncertainty: 
1-4 
Higher scores 
indicating higher 
levels of state anxiety 
level. 
 
 
 
 
Responses will be 
averaged for a total 
symptom uncertainty 
score. Higher scores 
indicate lower levels 
of uncertainty the 
symptoms 
experienced were 
heart related. 
 
Coping 
Processes 
Time to Seek 
Treatment  
 
Delay time in minutes 
from OS to time to seek 
treatment.  
 
   Delay time will be 
dichotomized for 
group analysis into 
those with a delay 
time of < 120 minutes 
or those with delay 
time > 120 minutes. 
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Appendix B 
Letter of Permission from Dr. Julie Zerwic 
 
RE: question from doctoral student in Ga.  
Julie Zerwic [juljohns@uic.edu]  
Sent:  Wednesday, March 17, 2010 3:18 PM  
To:  Deonna Tanner  
Attachments:                 ) ; Myocardial Infarct                                  -                 ) 
 
 
 
      
I am including the measure and have also attached my CV so you can see 
our other work in the area.  Good luck on your research. 
 
-----Original Message----- 
From: Deonna Tanner [mailto:DeonnaTanner@mail.clayton.edu]  
Sent: Tuesday, March 16, 2010 3:37 PM 
To: Julie Zerwic 
Subject: question from doctoral student in Ga. 
 
Dr. Zerwic,  
I am currently a second year PhD student at Georgia State University in 
Atlanta, Ga and am interested in your work. My research interest is 
older adults and their delay in treatment seeking when experiencing 
symptoms of AMI. I am attempting to locate a copy of the instrument, 
Myocardial Infarction Symptoms Profile (MISP). Any information you 
could 
give me would be helpful. 
 
Thank you for your time. 
 
Dee Tanner, MSN, RN, PhD student GSU 
deonnatanner@clayton.edu<mailto:deonnatanner@clayton.edu> 
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Appendix C 
Letter of Permission from Dr. Kathleen Dracup 
 
RE: question from doctoral student in ga  
Dracup, Kathleen [kathleen.dracup@nursing.ucsf.edu]  
Sent:  Monday, March 08, 2010 2:20 PM  
To:  Deonna Tanner  
Attachments:  Respons                                 ) 
 
 
 
      
Dear Dee, 
I'm attaching the questionnaire and hope that it is helpful in your 
work. Please feel free to use it or modify it. 
Best, 
Kathy Dracup 
 
-----Original Message----- 
From: Deonna Tanner 
[https://swanmail.clayton.edu/owa/redir.aspx?C=633911a45c814b6692db584a
16ee9d8d&URL=mailto%3aDeonnaTanner%40mail.clayton.edu]  
Sent: Saturday, March 06, 2010 3:46 PM 
To: Dracup, Kathleen 
Subject: question from doctoral student in ga 
 
Dr. Dracup, 
I am a second year doctoral student at Georgia State University in 
Atlanta, Ga. I am interested in older adults and their delay in seeking 
care when experiencing symptoms of AMI. Can you tell me how to locate 
the Response to Symptoms Questionnaire (RSQ)? I have several articles 
which have used this instrument and I would like to see it in its 
entirety. Any information would be helpful, I appreciate your time and 
effort. 
Thanks Again, 
 
Dee Tanner, MSN, RN 
Assistant Professor of Nursing 
Clayton State University 
678-466-4950 
deonnatanner@clayton.edu<mailto:deonnatanner@clayton.edu> 
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Appendix D 
MISS 
ID # ____________ 
 
 MYOCARDIAL INFARCTION SYMPTOMS SURVEY  
 
This is a questionnaire designed to gather a complete description of your experience 
during your heart attack.  The questionnaire includes items about the symptoms you 
experienced during and prior to your heart attack, the actions you took, and how you 
accessed the health care system. Please take your time answering the questions.  
 
1. When did you first notice your heart attack symptoms?  
 
Date_______________                                 Time_______________ 
          day/month/year                                               24 hour clock 
 
2. What time did you arrive in the emergency department?   
  
Date_______________                                 Time_______________ 
          day/month/year                                               24 hour clock 
                                    
            How do you remember that time?  (Did you look at a clock when you got 
into the ED?  Was there some other event, such as a television program,  
that helped you remember the time?     
                                                       
 
3. What time did you leave to come to the ED?       
 
Date_______________                                 Time_______________ 
          day/month/year                                               24 hour clock 
 
How do you remember that time?  (Did you look at a clock  
when you got into the ED?  Was there some other event, such  
as a television program, that helped you remember the time? 
                                                                     
 
4.       How did you arrive in the emergency department? Mode of transportation.  
             rescue squad (ambulance) 
  family member drove me  
  friend drove me  
  drove self 
  came by public transportation (cab, bus) 
  other, please specify ___________________                 
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5.       Where were you when you first noticed your heart attack symptoms?  
1. at home 
2. at work 
3. in a vehicle 
4. visiting friends or relatives 
5. in a public place (for example, restaurant, movie, theater, hotel,  
                              meeting) 
6.       other, please specify_________________ 
 
7.      What were you doing when your heart attack symptoms started? 
 
 
8.      When you FIRST noticed your symptoms did you think the problem was (one  
     answer only) 
1. your heart 
2. indigestion or stomach problems 
3. muscle pain (includes back pain, shoulder pain, etc.) 
4. fatigue 
5. flu or flu-like illness 
6. dental problem 
7. breathing problem 
8. Other please specify __________________________ 
 
8.         How similar were your symptoms with what you thought a heart attack would be  
            like?  
 
1                              2                                3                                4                               5 
not at all similar         mildly similar        moderately similar           very similar           extremely similar 
 
 
9.        What about your experience was similar with what you expected a heart attack  
           would be like?  
 
 
10.      What about your experience was not similar with what you expected a heart attack 
           would be like? 
   
 
11.      Which of the following describes how your discomfort started with your heart   
           attack? Descriptive for symptom interpretation 
  Started very abruptly 
  Began gradually and reached its peak over several minutes 
  Began gradually and reached its peak after at least 30 minutes 
 
       12.      Please rate the intensity of the discomfort you experienced with your heart attack 
            when the discomfort first started on the scale below:  
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0  1   2   3   4   5   6   7   8   9   10 
No                                                                                                             The worst it 
Discomfort                                          could be 
 
13.      When you first noticed your symptoms were you:  
1. with your spouse or partner 
2. with another family member, please specify relationship  
                               __________________ 
3. with friends 
4. with people at work 
5. other, please specify_______________________ 
  
14.      How did other people respond to you when you told them about your symptoms? 
           (This question refers to lay people—one answer only)  
  
1. they said or did nothing 
2. they told me not to worry 
3. they tried to comfort me 
4. they suggested I rest and take medicine 
5. they suggested I get medical help 
6. they called the emergency system to get help for me 
7. they took me to the hospital  
8. they got upset 
9. I never told anyone about my symptoms 
10. Other, please specify______________________ 
 
15.       Please quantify the degree to which this person’s response was helpful in making 
the decision to seek treatment for your symptoms. scored from “1” (very helpful) 
to “5” (not at all helpful) in the decision to seek treatment.  
 
1                              2                                3                                4                               5 
not at all helpful          mildly helpful        moderately helpful           very helpful       extremely 
helpful 
 
   
16.       I am going to read a list of locations where you may have experienced 
pain/discomfort.  I would like you to tell me which apply to you. You are also 
asked to rate on a 1-4 scale how certain you were that the pain/discomfort was 
related to your heart. A rating of “1” indicates you were not at all sure the 
symptoms experienced were related to the heart, “2” you were somewhat certain, 
“3” moderately certain and a rating of “4” indicates you were 100 % sure that the 
symptom experienced was related to their heart. 
                      
 
 NO   YES 
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16.1     Center of chest ...............................................................................................................  
Certainty Rating   .................................................................................................  
16.2     Left side of chest ...........................................................................................................  
Certainty Rating ...................................................................................................  
16.3     Right side of chest .........................................................................................................  
Certainty Rating ...................................................................................................  
16.4     Left shoulder .................................................................................................................  
Certainty Rating ...................................................................................................  
16.5     Right shoulder ...............................................................................................................  
Certainty Rating ...................................................................................................  
16.6     Left arm .........................................................................................................................  
Certainty Rating ...................................................................................................  
16.7    Left hand (including fingers) ..........................................................................................  
Certainty Rating ...................................................................................................  
16.8    Right arm ........................................................................................................................  
Certainty Rating ...................................................................................................   
16.9    Right hand (including fingers) ........................................................................................  
Certainty Rating ...................................................................................................  
16.10    Center of back (between shoulder blades) ....................................................................  
Certainty Rating ...................................................................................................  
16.11    Lower back ................................................................................................................  
Certainty Rating ...................................................................................................  
16.12    Upper Abdomen ...........................................................................................................  
Certainty Rating ...................................................................................................  
16.13    Lower Abdomen ...........................................................................................................  
Certainty Rating ...................................................................................................   
16.14    Left leg/foot ..................................................................................................................  
Certainty Rating ...................................................................................................  
16.15     Right leg/foot ...............................................................................................................  
Certainty Rating ...................................................................................................  
16.16     Front of Neck...............................................................................................................   
Certainty Rating ...................................................................................................  
16.17     Back of Neck ............................................................................................................  
Certainty Rating ...................................................................................................  
16.18     Throat ..........................................................................................................................  
Certainty Rating ...................................................................................................  
16.19     Jaw ...............................................................................................................................   
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Certainty Rating ...................................................................................................  
16.20     Teeth ............................................................................................................................  
Certainty Rating ...................................................................................................  
16.21      Cheeks ........................................................................................................................  
Certainty Rating ...................................................................................................  
16.22     Ears ...............................................................................................................................  
Certainty Rating ...................................................................................................  
  
 
17.    I am going to read to you a list of words people use to describe different types of 
      pain or discomfort. I would like you to tell me which words described what you  
      were feeling.  
   
                  Physical symptoms of AMI 
      
[*If subject indicates yes to a particular sensation, ask where this sensation is 
felt/ located).   
 
           *Location                                                              No        Yes          
17.1 Pressing  
17.2 Squeezing  
17.3 Strangling  
17.4 Constricting  
17.5 Dull ache  
17.6 Burning    
17.7 Band across my chest  
17.8 Weight in the center of my chest  
17.9 Pain  
17.10 Discomfort  
17.12 Stabbing  
17.13 Jabbing  
17.14 Vise-like  
17.15 Suffocating  
17.16 Crushing  
17.17 Heaviness  
17.18 Numbness  
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17.19 Pressure  
17.20 Tingling  
17.21 Choking  
17.22 Fullness  
17.23 Tightness  
   
Are there any other words you would use to describe the discomfort?   
 
 
List words ____________________________________________________ 
and location    __________________________________________________      
 
                                                  
 
18. Some people experience other symptoms along with or instead of chest discomfort.  I 
am going to read a list of other possible symptoms or sensations and I would like you to 
tell me if you experienced these symptoms. You are also asked to rate on a 1-4 scale how 
certain you were that the pain/discomfort was related to your heart. A rating of “1” 
indicates you were not at all sure the symptoms experienced were related to the heart, “2” 
you were somewhat certain, “3” moderately certain and a rating of “4” indicates you 
were 100 % sure that the symptom experienced was related to their heart. 
                                                                          No          Yes     
18.1 Belching  
Certainty Rating  
18.2 Nausea  
Certainty Rating  
18.3 Indigestion  
Certainty Rating  
18.4 Dizziness  
Certainty Rating  
18.5 Sweating  
Certainty Rating  
18.6 General weakness  
Certainty Rating    
18.7 Numbness or tingling in your hands  
Certainty Rating  
18.8 Numbness or tingling in your feet  
Certainty Rating  
18.9 Shortness of breath  
Certainty Rating  
18.10 Vomiting  
Certainty Rating  
18.11 Palpitations/funny beating of your heart  
Certainty Rating   
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18.12 Fainting  
Certainty Rating  
18.13 Lightheaded  
Certainty Rating  
18.14 Leg cramps  
Certainty Rating  
18.15 Fear or fright  
Certainty Rating  
18.16 Fatigue/tiredness  
Certainty Rating  
18.17 Headache   
Certainty Rating  
 
 
  Are there any other symptoms that you have experienced along with your chest 
 
   
  Please Describe any other symptoms: 
  
 
19.      Which of the following things did you try, in order to see if it would eliminate 
your symptoms or discomfort during your heart attack?  (1- no 2- yes, relieved 
symptoms 3- did not relieve 4- unsure if it helped)          
   
19.1 Breathing or taking a deep breath    
19.3 Twisting or turning the body  
19.4 Sitting or standing quietly  
19.5 Eating foods or drinking a beverage   
19.6 Antacids such as Maalox or Riopan  
19.7 Burping or belching  
19.8 Nitroglycerine  
19.9 Lying flat on bed/floor  
19.10 Aspirin, tylenol or some other pain reliever  
19.11 Walking around  
19.12 Stopping the activity you were doing  
 
 
20.       When you first experienced your symptoms how serious did you think they were? 
      1                         2                                3                                4                               5  
not at all               mildly                      moderately                  very                 extremely 
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 21.       What was the FIRST thing that you did when you FIRST noticed your symptoms?  
(one answer only)  
1. wished or prayed that they would go away 
2. tried to relax 
3. pretended nothing was wrong 
4. told someone 
5. tried not to think about my symptoms 
6. took medication (for example, antacid, nitro, acetaminophen) 
7. called my doctor 
8. tried self-help remedy (changing position, herbs, etc.) 
9. told someone who was nearby (friend, co-worker, stranger, etc.) 
10. called the emergency system 
11. transported myself or had someone transport me to the hospital 
12. drove to the doctor’s office or clinic 
13. Other please specify___________________________________ 
      
22.       How much ability to control your symptoms do you think you have?  
1                              2                                3                                4                           5  
not at all               mildly                         moderately                very                extremely 
 
                                                                                                                                                                                                                                                                                  
23.       What types of things did you do between your arrival in the emergency 
            department and the time your symptoms started?  
 
________________________________________________________________________
________________________________________________________________________
________________________________________________________________________ 
 
           Specifically ask about: Professional Support 
                                                                                                                                                                                                                                                                                           
            Did you call a health care provider such as a general practitioner, nurse,  
           EMT/paramedic?   
  
time:_________________                        
23 a. Please quantify the degree to which this healthcare provider’s response was  
helpful in making the decision to seek treatment for your symptoms. scored from 
“1” (very helpful) to “5” (not at all helpful) in the decision to seek treatment. 
Professional support 
                                                                                                                                       
1                              2                                3                                4                               5 
not at all helpful      mildly helpful     moderately helpful    very helpful          extremely helpful 
  
 
 
What was their response or specific recommendations to you?     
__________________________________________________________________
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__________________________________________________________________
__________________ 
 
Did they sp  
 
                                                                          
 other please specify _________________________________                                                                                                                                            
                                                                                                          
                                                                                                             
How important were the following factors in causing you to delay seeking help 
for your symptoms? 
 
24.       You delayed because you waited to see if your symptoms would go away. 
                 
1                              2                                3                                4                               5 
not at all              mildly                    moderately                 very                     extremely 
 
 
25.       You delayed because your symptoms came and went. 
          
1                              2                                3                                4                               5 
not at all              mildly                    moderately                 very                     extremely 
  
 
26.       You delayed because you did not realize the importance of your symptoms. 
 
1                              2                                3                                4                               5 
not at all              mildly                    moderately                    very                     extremely 
 
 
     27.        Did you have more than one episode of symptoms prior to your heart attack?  
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Appendix E 
Patient Characteristics Form 
        ID #______________ 
Patient Characteristics Form 
Please answer the following questions by filling in the blank space or by checking the 
choice that best matches your situation. 
 
1.  What is your gender?   
 � Male  _____   
            � Female _____      
 
2.    What is your age? _____ years old  
 
3.   What is your marital status (choose one)? 
� Single, Never married 
� Married 
� Living with a Partner 
� Separated or Divorced 
� Widowed 
� Other: _________________ 
 
4.  What is your racial group (choose one)? 
� White/Caucasian 
� Black/African American 
� Hispanic/Latino 
� Native American/Alaska Native 
� Asian/Pacific Islander 
� One or more mixed group 
  
5.   What is your last grade completed (choose one)?   
      � 8th grade or less 
� Some high school 
� High school graduate or GED 
� Some college or technical school 
� College graduate (bachelor’s degree) 
� Graduate degree (master’s or doctorate)  
       
 
6.   Living arrangements: Do you own a home? � yes � no  
Total # people living with you _____ 
Who lives with you? Please check all that apply.  
� Spouse                          � Child                              � Friend 
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� Parent                           � Partner                            � Other family member 
� Sibling                          � Paid assistant/caretaker   Other ________ 
     
7. What is your employment status (choose one)?   
            � Working Full Time, 35 hours to 40 hours a week 
� Working Part Time, less than 35 hours a week 
� Retired or unemployed  
� Disabled, not able to work  
   
8.  What is your annual household income (choose one): 
� Less than $20,000               � $81,000 to $100,999 
� $21,000 to $40,999               � $Above $101,000 
� $41,000 to $60,999               � prefer not to answer 
� $61,000 to $80,999 
 
 
9.  Do you have access to a home telephone or cellular phone?  
� yes  
� no 
 
If you answered yes, is your phone always on and/or working? 
� yes  
� no 
 
10.       Did you have a cell phone with you when you experienced symptoms of a heart  
            attack?  
 
� yes  
� no 
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Appendix F 
AMI Clinical Data Extraction Form 
 
 ID # ____________________ 
AMI Clinical Data Extraction Form 
1)  Presenting symptoms of AMI: 
________________________________________________________________________
________________________________________________________________________ 
 
2)  History of diabetes mellitus (DM)?  � yes (1) � no (0) 
 
3)  Previous history AMI? � yes (1) � no (0) 
4)  AMI location as identified on EKG: _______________________________ 
5)  Self reported pain level on arrival (using universal pain scale 0-10)  
0  1   2   3   4   5   6   7   8   9   10 
No                                                                                       The worst it could be 
Pain/ Discomfort         
         
                
6)  Initial cardiac enzyme levels: 
Troponin I ___________ 
    CK-MB_______ 
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Appendix G 
Informed Consent 
 
Georgia State University  
School of Nursing 
Informed Consent 
 
Title: The Examination of Factors Which Influence Treatment Seeking Delay Among 
Older Adults Diagnosed with Acute Myocardial Infarction. 
 
Principal Investigator:  Cecelia Grindel, PhD, CMSRN, FAAN 
                                      Deonna Tanner, PhD (c), MSN, RN, Student P.I. 
   
I. Purpose:   
You are invited to participate in a research study. The purpose of this study is to 
examine the relationship of factors which influence the prolonged delay in 
seeking treatment among older adults diagnosed with an acute myocardial 
infarction (heart attack). You are invited to participate because you are between 
60-80 years of age and have recently had a heart attack. A total of 122 participants 
will be recruited for this study. Participation will take about 60-90 minutes of 
your time.  
 
II. Procedures:  
If you take part in this study, you will be asked about what happened when your 
heart attack symptoms started. We will also ask what made you decide to get 
treatment. The interview will take place in a private place like your hospital 
room. It will take about 60-90 minutes. The interview can be done in one or more 
sessions, it is your choice.   
 
III. Risks:  
In this study, you will not have any more risks than you would in a normal day of 
life. If you become tired or have pain during the interview, the researcher will 
come back at a later time. The researcher will also notify your nurse. You may 
become sad or upset when talking about your heart attack. If this happens, the 
researcher will talk to you about your feelings. The researcher will also notify 
your nurse. Counseling services may also be offered to you. 
 
IV. Benefits:  
Participation in this study may not benefit you personally. We hope to gain 
information about how older adults make the decision to seek treatment for a heart 
attack. 
 
V. Voluntary Participation and Withdrawal:  
Participation in this study is voluntary. You do not have to be in this study.  If 
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you decide to participate and change your mind, you have the right to drop out 
at any time without any type of consequence. You may skip questions or stop 
participating at any time.  Whatever you decide, you will not lose any benefits 
to which you are entitled. Participation in this study will not affect your medical 
care. 
 
 
VI. Confidentiality:  
We will keep your records private to the extent of the law. The researchers will 
have access to your information. Information may also be shared with those who 
make sure the study is done correctly (GSU Institutional Review Board, and/or 
the Office for Human Research Protection). We will use an ID code assigned to 
you rather than your name on study records. The information you provide and 
consent forms will be stored in a locked cabinet and only the researchers will have 
access. The key (code sheet) will be used to identify you. This will be stored 
separately from the data on a password protected computer. The information and 
the key (code sheet) will be destroyed one year after the study is done. Your name 
and facts that may identify you will not appear when we present this study or 
publish its results. The findings will be summarized and reported as a  group. You 
will not be identified personally.  
 
 
We are also requesting permission to access your medical record. We will keep 
your personal information private and your privacy will be kept to the extent of 
the law. The health information you give us will be used in this study and we will 
remove all identifying information. If you decide you want to be in this study, it 
means that you agree to let us use and share your health information for the 
reasons we have listed in this form. While we are doing this research, the 
researchers may use only the health information you have given us permission to 
get from your record. This information is relevant to your heart attack and 
includes:  
 heart attack symptoms 
 previous history of heart attack 
 heart attack location  
 your pain level when you got to the hospital  
 history of diabetes mellitus  
 cardiac enzyme levels on arrival to hospital (troponin I and CK-MB)   
 how you arrived at the hospital (car, ambulance)  
 medical or surgical intervention you received 
 
Only the research team will see your health information. We may also share your 
health information with the Georgia State University Institutional Review Board. 
Your health information may be shared by the people or places we have listed, but 
it will be shared in a way that does not fall under the protection of federal 
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regulations that apply to the privacy of health information. This research may be 
published, but we will make sure that you cannot be identified.  
 
If you sign this consent form you are letting us use your health information. You 
have the right to say that you do not want us to use your health information after it 
is collected. If you decide you do not want us to use your information you must 
call or email the student PI. This will be the only person who will be able to know 
which information is yours. You may not be able to look at or get a copy of your 
health information while we are doing the research. You will be able to look at or 
get a copy at the end of the study. 
 
 
VII.    Contact Persons:  
For questions about your participation in this study contact: 
 Cecelia Grindel at 404-413-1167 or cgrindel@gsu.edu 
 Deonna  Tanner at 770-900-2681 or deonnatanner@clayton.edu 
 If you have questions or concerns about your rights as a participant, contact 
Susan Vogtner in the Office of Research Integrity at 404-413-3513 or 
svogtner1@gsu.edu 
 
 
VIII. Copy of Consent Form: 
 
We will give you a copy of this form.   
 
Please sign below if you volunteer for this study and give us permission to access 
to your personal medical information.  
 
 
__________________________________________ _____    _______________ 
 Participant       Date  
 
_____________________________________________ ________________ 
         Researcher Obtaining Consent                                                   Date 
 
 
